Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 56
|
ECE2018
|
Next issue
20th European Congress of Endocrinology
Barcelona,
Spain
19 May 2018 - 22 May 2018
All volumes
0105 UKINETS2024
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
ECE 2018, 19 - 22 May 2018; Barcelona, Spain
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
20th European Congress of Endocrinology 2018
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
A gut feeling about glucagon
ea0056eje1
The European Journal of Endocrinology Prize Lecture
ea0056eje1biog
The Geoffrey Harris Prize Lecture
Geoffrey Harris Award
ea0056gh1
The Geoffrey Harris Prize Lecture
ea0056gh1biog
European Hormone Medal Lecture
Unraveling Secrets of the Hypothalamic-Pituitary-Gonadal Axis
ea0056ehm1
European Hormone Medal Lecture
ea0056ehm1biog
Clinical Endocrinology Trust Lecture
Growth Hormone: not too much… not too less..!
ea0056cet1
Clinical Endocrinology Trust Lecture
ea0056cet1biog
Plenary Lectures
Contraception: Past and future
Contraception: past, present, and future
ea0056pl1
Bone regulates the Brain
Bone Regulates the Brain to Control Appetite
ea0056pl2
The wonder world of GnRH neurons
The wonder world of GnRH neurons - cracking the pulse generator
ea0056pl3
The Retina as a Window for Exploring the Brain in Diabetes
The Retina as a Window for Exploring the Brain in Diabetes
ea0056pl4
The link between insulin and fatty liver
The link between insulin and fatty liver
ea0056pl5
Does therapy for thyroid dysfunction decrease mortality?
Does therapy for thyroid dysfunction decrease mortality?
ea0056pl6
Metabolic control of longevity
Anti-obesity effect in mice and monkeys of partial inhibition of PI3K[alpha]
ea0056pl7
Symposia
Predicting events in autoimmune thyroid diseas
The THEA score in familial thyroid dysfunction. Predictive factors of autoimmune thyroid disease
ea0056s1.1
IgG4 related thyroid autoimmune disease
ea0056s1.2
New scores for the prediction of Graves' disease
ea0056s1.3
Salt & Sweet
Hyponatremia and mortality: moving beyond associations
ea0056s2.1
Hereditary diabetes insipidus
ea0056s2.2
Going hedonic - the role of FGF21 in the preference for sweet and alcohol
ea0056s2.3
Bile Acid & Microbiota (Endorsed by Endocrine Connections)
Crosstalk between bile acids and the gut microbiota - influence on host metabolism
ea0056s3.1
Subclinical hypothyroidism is 'not' a disease (Contra)
ea0056s3.2
Bile acids and metabolic effects of bariatric surgery
ea0056s3.3
Environmental effects on endocrine functions
Developmental exposures to endocrine disrupting chemicals (EDCs) reprogram the epigenome to increase risk for hormone-dependent cancers and other diseases of adilthood
ea0056s4.1
Iodine deficiency in pregnancy and development of offspring
ea0056s4.2
Environmental contaminants and endocrine disruption: the story of obesogens
ea0056s4.3
The role of sperm epigenome in fertility and inheritance
The quality control of the male germline transcriptome
ea0056s5.1
Abstract unavailable
ea0056s5.2
Mechanisms of epigenetic inheritance through sperm: lessons we have learnt from model organisms
ea0056s5.3
Precision Medicine for diabetes (Endorsed by the European Journal of Endocrinology)
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
ea0056s6.1
Genetics can help to improve precision medicine in diabetes
ea0056s6.2
Precision Nutrition in Obesity: gene-diet interactions
ea0056s6.3
Expanding the spectrum of thyroid hormone use (Endorsed by the European Journal of Endocrinology)
Triac: hormone, metabolite and drug.
ea0056s7.1
Tetrac as an antiangiogenic agent in cancer
ea0056s7.2
Thyroid hormones, metabolites, and analogs: Potential therapies for non-alcoholic fatty liver disease and other metabolic conditions
ea0056s7.3
Bone fragility - from bench to clinic
Clinical spectrum of new monogenic forms of osteoporosis
ea0056s8.1
Abstract unavailable
ea0056s8.2
Hypophosphatasia - diagnosis and treatment
ea0056s8.3
EAA /ESE Session: Male gonadal function versus general health and vice versa
Abstract unavailable
ea0056s9.1
Klinefelter syndrome - a challenge for endocrinologists
ea0056s9.2
Does 'healthy obesity' exist in andrology?
ea0056s9.3
Hot topics in NETs
Whole genome landscape in pancreatic neuroendocrine tumours
ea0056s10.1
Abstract unavailable
ea0056s10.2
Treatment update on carcinoid syndrome and carcinoid heart disease
ea0056s10.3
Novel aspects of Craniopharyngioma
Molecular pathogenensis of craniopharyngioma
ea0056s11.1
Bariatric surgery as treatment in craniopharyngioma
ea0056s11.2
The psychosocial, neuroendocrine and cognitive effects of childhood craniopharyngioma
ea0056s11.3
Why do fractures occur in endocrine disorders, and how should they be handled?
Abstract unavailable
ea0056s12.1
Bone quality evaluation in Pituitary diseases
ea0056s12.2
Parathyroid dysfunctions - bone mass and fractures in primary hyperparathyroidism
ea0056s12.3
The colours of fat
Brown adipose tissue as an endocrine organ
ea0056s13.1
Adipose tissue browning in mice and men
ea0056s13.2
Browning of adipose tissue in humans
ea0056s13.3
Neuroendocrine basis of reproductive disorders
Developmental wiring of GnRH neurons
ea0056s14.1
Neuroendocrinology right from the nose: Genetics and pathophysiology of the olfacto-genital syndrome (Kallmann syndrome)
ea0056s14.2
Abstract unavailable
ea0056s14.3
EYES: New aspects in the study of neuroendocrine diseases
Introduction to EYES
ea0056s15.1
Abstract unavailable
ea0056s15.2
Epigenetic and metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas
ea0056s15.3
Abstract unavailable
ea0056s15.4
Abstract unavailable
ea0056s15.5
Abstract unavailable
ea0056s15.6
Changing practice in the management of thyroid neoplasms
New steps in the genomic alterations of thyroid malignancies
ea0056s16.1
Composite approach in the evaluation and management of thyroid nodule
ea0056s16.2
Abstract unavailable
ea0056s16.3
Recent advances in Primary Adrenal Macronodular Hyperplasia
Adrenal development and benign tumor formation
ea0056s17.1
Genetics of Primary Bilateral Macronodular Adrenal Hyperplasia: when and what to test
ea0056s17.2
Diagnosis and Management of Primary Adrenal Macronodular Hyperplasia
ea0056s17.3
Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Sex hormones, obesity and type 2 diabetes-is there a link?
ea0056s18.1
Relevant therapies in PCOS
ea0056s18.2
Testosterone, obesity and the metabolic syndrome in males-do we need to replace steroids?
ea0056s18.3
New Aspects of Pituitary Regulation
Cytoskeleton, pharmacologic resistance and clinical aggressiveness in pituitary tumours
ea0056s19.1
What fat does with your pituitary
ea0056s19.2
How cancer treatment effects your pituitary
ea0056s19.3
All you need to know about lipodystrophy (Endorsed by Endocrine Connections)
Lipodystrophy as a model for prevalent insulin resistance
ea0056s20.1
Acquired forms of lipodystrophy
ea0056s20.2
Lipodystrophies, diagnosis and treatment: a step-by-step approach
ea0056s20.3
The Dance of Adrenal and Gonads (Endorsed by Endocrine Connections)
Abstract unavailable
ea0056s21.1
Management of phaeochromocytoma during pregnancy
ea0056s21.2
Fertility in Congenital Adrenal Hyperplasia
ea0056s21.3
The fatty bone
Abstract unavailable
ea0056s22.1
Bone marrow adipose tissue: starving for attention
ea0056s22.2
Cross-talk between bone marrow and peripheral adipose tissue in man
ea0056s22.3
Pre-diabetes
Abstract unavailable
ea0056s23.1
Abstract unavailable
ea0056s23.2
Treatment of Pre-Type 2 Diabetes
ea0056s23.3
Ups and downs of hypothalamo-pituitary hormones
How Does Pituitary Release its Hormones?
ea0056s24.1
Peripheral activities of growth hormone-releasing hormone (GHRH)
ea0056s24.2
The role of pituitary hormones (among others) in the generation of metabolic stress responses
ea0056s24.3
Late Breaking
Extracellular Vesicles: from waste-containers to new opportunities
ea0056s25.1
Senescence-associated reprogramming promotes cancer stemness
ea0056s25.2
LEAP2 is an Endogenous Antagonist of the Ghrelin Receptor
ea0056s25.3
Cortisol: Too much of a Good Thing
Genetics of Cushing's disease
ea0056s26.1
Hypercortisolism and the brain
ea0056s26.2
Differentiating Cushing from Pseudo-Cushing
ea0056s26.3
Emerging treatments in osteoporosis
Abstract unavailable
ea0056s27.1
Novel therapies: PTH-related protein and sclerostin inhibition
ea0056s27.2
Sequential and combination therapy for osteoporosis.
ea0056s27.3
Endocrinology Meets Immunology
Abstract unavailable
ea0056s28.1
Abstract unavailable
ea0056s28.2
Immunotherapy Related Endocrinopathies
ea0056s28.3
Thyroid hormone action: regulation and clinical implications
Tissue-specific regulation of thyroid hormone action
ea0056s29.1
Thyroid hormone economy in human aging
ea0056s29.2
Abstract unavailable
ea0056s29.3
Disorders of Sexual Development (DSD)
Abstract unavailable
ea0056s30.1
Atypical Genital Development and Hypospadias: a Pediatric Urology perspective from Etiology to Surgery
ea0056s30.2
Brain structure and function in gender dysphoria
ea0056s30.3
Special Symposium: Bone & Vitamin D (Endorsed by Endocrine Connections)
Free and bound vitamin D and health outcomes.
ea0056ss1.1
Vitamin D in critical illness
ea0056ss1.2
The effects of Vitamin D deficiency on macrophages function, cholesterol metabolism and cardiometabolic disease
ea0056ss1.3
Guidelines: ESE - ENSAT guidelines on the management of adrenocortical carcinoma in adults
ESE - ENSAT guidelines on the management of adrenocortical carcinoma in adults
ea0056gl1.1
Abstract unavailable
ea0056gl1.2
Abstract unavailable
ea0056gl1.3
Abstract unavailable
ea0056gl1.4
Abstract unavailable
ea0056gl1.5
Abstract unavailable
ea0056gl1.6
Endo-ERN: concrete examples of added value for patient care
Introduction, structure, and virtual consultation using the EU-ERN CPMS
ea0056ern1.1
Caring for endocrinology across the life span: DSD and Hypogonadotropic hypogonadism
ea0056ern1.2
ESE Endo-ERN symposium: Patient and family perspectives, Manuela Brosamle, Endo-ERN ePAG
ea0056ern1.3
New Scientific Approaches
(1)
Abstract unavailable
ea0056nsa1
A comprehensive map of splicing alterations in small cell lung cancer
ea0056nsa2
Reprgrammin strategies to obtain functional endocrine units; focus on the adrenal cortex
ea0056nsa3
3D visualisation of the HPG axis in mice and humans
ea0056nsa4
Circulating miRNAs in endocrine tumours
ea0056nsa5
Abstract unavailable
ea0056nsa6
Debates
Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats! (Endorsed by the European Journal of Endocrinology)
Adrenal venous sampling vs imaging for primary aldosteronism
ea0056d1.1
Against - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
ea0056d1.2
Receptor profiling is useful for predicting pituitary therapy (Endorsed by the European Journal of Endocrinology)
Abstract unavailable
ea0056d2.1
Abstract unavailable
ea0056d2.2
Subclinical hypothyroidism is a disease
FOR - subclinicl hypothyroidism is a disease
ea0056d3.1
Abstract unavailable
ea0056d3.2
AMH as the Primary Marker for Fertility
AMH is the primary marker for fertility (Pro)
ea0056d4.1
Debate: AMH as the primary marker for fertility
ea0056d4.2
Pregnant women should be screened for thyroid hormones and antibodies
Abstract unavailable
ea0056d5.1
AGAINST: 'Pregnant women should be screened for thyroid hormones and antibodies'
ea0056d5.2
Endocrine disruptors: Regulatory vs. Scientific Perspectives (Endorsed by Endocrine Connections)
Abstract unavailable
ea0056d6.1
Endocrine disruptors: Regulatory vs. Scientific Perspectives (regulatory view point)
ea0056d6.2
Meet the Expert Sessions
(1)
Using diabetes technologies to improve patient self care
ea0056mte1
Acromegaly: Optimal management after surgery
ea0056mte2
Managing delayed puberty
ea0056mte3
Osteoporosis in men: management of bone health in the endocrine outpatient clinic
ea0056mte4
Medullary thyroid cancer beyond surgery
ea0056mte5
Long-term implications of hypoglycaemia in diabetes Dr Ilhan Satman, Istanbul University, Turkey
ea0056mte6
Difficult cases of differentiated thyroid cancer
ea0056mte7
Hormone replacement for the travelling patient
ea0056mte8
Premature ovarian insufficiency: an endocrine perspective
ea0056mte9
The effect of gender-affirming therapy on bone in transgender persons
ea0056mte10
How to integrate PCSK9 inhibitors into hyperlipidemia management
ea0056mte11
Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
ea0056mte12
Erectile dysfunction
ea0056mte13
Vitamin D for everybody?
ea0056mte14
Your emergency consult about hyponatraemia
ea0056mte15
Adrenal Incidentaloma
ea0056mte16
Abstract unavailable
ea0056mtbs1
Single-cell technologies in development and disease with a special emphasis on endocrine systems
ea0056mtbs2
Watch out for noncanonical mechanisms of thyroid hormone action!
ea0056mtbs3
Nurse Sessions
(1)
Abstract unavailable
ea0056n1.1
Abstract unavailable
ea0056n1.2
Abstract unavailable
ea0056n1.3
Abstract unavailable
ea0056n2.1
Abstract unavailable
ea0056n2.2
Abstract unavailable
ea0056n2.3
Abstract unavailable
ea0056n2.4
Nursing Management of Congenital Adrenal Hyperplasia (CAH): - Education, Managment and use of Multi-Media Technology
ea0056n3.1
Abstract unavailable
ea0056n4.1
Abstract unavailable
ea0056n4.2
Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance testing with two different doses (0.15 vs 0.10 U/kg)
ea0056n4.3
Cooperation between an endocrine nurse, psychologist and physician and their role in the care of depression in patients treated with multi kinase inhibitors due thyroid cancer
ea0056n4.4
Abstract unavailable
ea0056n4.5
Oral Communications
Benign thyroid diseases
Familial gestational hyperthyroidism caused by Val597ile mutant of TSH receptor gene with human chorionic gonadotropin hypersensitivity
ea0056oc1.1
Relationship between TSH values in the first trimester of pregnancy and obstetric and neonatal complications
ea0056oc1.2
Thyroid hormone replacement therapy for subclinical hypothyroidism in adults: systematic review and meta-analysis of randomized-controlled trials
ea0056oc1.3
The impact of obligatory iodine prophylaxis on thyroid volume in schoolchildren
ea0056oc1.4
Low free T3 levels within the reference range independently predict cardiovascular mortality in the general population
ea0056oc1.5
Look who is controlling your gonads!
The in vivo and in vitro effects of kisspeptin on human ovarian function
ea0056oc2.1
Overexpressed kisspeptin/Kiss1R system in human granulosa cells may be involved in the pathogenesis of polycystic ovary syndrome (PCOS) by inhibiting ovulation
ea0056oc2.2
Whole exome sequencing in non-obstructive azoospermia allows the identification of a high-risk subgroup of infertile men for undiagnosed Fanconi Anemia, a cancer-prone disease
ea0056oc2.3
Novel role of central ceramide signaling in mediating obesity-induced precocious puberty
ea0056oc2.4
Effect of thyroxine replacement on leydig cell and sertoli cell function in men with hypothyroidism
ea0056oc2.5
New insights in bone disorders
A Phase 3 randomized, double-blind, placebo-controlled study investigating the efficacy and safety of Burosumab, an anti-FGF23 antibody, in adult X-Linked Hypophosphatemia (XLH)
ea0056oc3.1
Can a bone protein protect against muscular dystrophy?
ea0056oc3.2
[18F]-FDG PET/CT imaging: A tool to reveal the metabolic functions of bone marrow adipose tissue
ea0056oc3.3
Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy
ea0056oc3.4
Change in bone mineral density during the first 10 years of gender affirming hormonal treatment in transwomen and transmen
ea0056oc3.5
Novel insights into prediabetes and type 2 diabetes
Dietary intervention modulates the expression of the splicing machinery in patients at high-risk of type 2 diabetes development: clinical implications
ea0056oc4.1
Toe brachial index predicts major adverse cardiovascular events in patients with type 2 diabetes
ea0056oc4.2
Effects of TRAIL delivery on an experimental model of type 2 diabetes and diabetic nephropathy
ea0056oc4.3
Association between prediabetes and incidence of chronic kidney disease, incident albuminuria, or worsening of kidney function: a secondary analysis of the SPRINT trial
ea0056oc4.4
The impact of prediabetes in lung function: data from the ILERVAS project
ea0056oc4.5
Diving deep into adrenal cortex diseases
Is adrenal computed tomography accurate for the diagnosis of unilateral primary aldosteronism? A retrospective international cohort study
ea0056oc5.1
Steroid profiling by liquid chromatography tandem mass spectrometry in a large cohort of patients with adrenal incidentalomas
ea0056oc5.2
PRKACA L206R mutation in adrenal Cushing's syndrome makes PKA RII[beta] susceptible for caspase-mediated cleavage
ea0056oc5.3
Assessment of Tissue Sodium Content by 23Na-MRI in Patients with Adrenal Insufficiency - a Pilot Study
ea0056oc5.4
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
ea0056oc5.5
Genetic and environmental determinants of obesity and insulin resistance
5[beta]-reductase (AKR1D1) is a potent regulator of hepatic insulin sensitivity, carbohydrate and lipid metabolism
in vitro
and
in vivo
ea0056oc6.1
Deep transcranial magnetic stimulation acutely modulates neuro-endocrine pathways underlying obesity
ea0056oc6.2
Visceral fat assessment in lamin A/C mutation carriers: phenotype -genotype correlation
ea0056oc6.3
Anthropometric measurements and metabolic syndrome in relation to glucocorticoid receptor polymorphisms in (local) corticosteroid users
ea0056oc6.4
Associations of different body fat deposits with serum 25-hydroxyvitamin D concentrations
ea0056oc6.5
Genomic and clinical aspects of endocrine tumours
Molecular classification of benign adrenocortical tumors: an integrated genomic study
ea0056oc7.1
Urine steroid metabolomics as a diagnostic tool for detection of adrenocortical malignancy - a prospective test validation study
ea0056oc7.2
LncRNAs profiling reveals epigenetic heterogeneity among human parathyroid tumor
ea0056oc7.3
Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier (SLC25A11) gene confer predisposition to metastatic paragangliomas
ea0056oc7.4
Randomized trial comparing phenoxybenzamine and doxazosine for preoperative treatment of patients with a pheochromocytoma (PRESCRIPT)
ea0056oc7.5
MicroRNAs as biomarkers in endocrine diseases
Plasma microRNA expression in patients with Cushing's disease differs from ACTH-ectopic Cushing's syndrome
ea0056oc8.1
MicroRNA expression profiling and functional annotation analysis of their targets in patients with diabetic kidney disease
ea0056oc8.2
Circulating levels of microRNAs associate with blood pressure and left ventricular mass in primary hypertensive patients
ea0056oc8.3
Detecting blood micro-RNAs and proteins associated with Graves' disease and orbitopathy
ea0056oc8.4
MicroRNA profiles in diabetic octogenarians with and without historical and prospective hip fractures
ea0056oc8.5
Thyroid from basics to clinics
Increased urinary iodide precedes hypothyroidism in Dehal1 knockout mice
ea0056oc9.1
Anti-tumoral effects of metformin on metastatic bone lesions of thyroid cancer
ea0056oc9.2
A mouse model of BRAF V600E mutated papillary thyroid cancer imitating sporadic conditions
ea0056oc9.3
Identification of an epigenetic biomarker panel for predicting the development of distant metastases in differentiated thyroid cancer
ea0056oc9.4
Sentinel lymph node biopsy using methylene blue dye in papillary and medullary thyroid carcinomas and microcarcinomas in decision for lateral neck dissection
ea0056oc9.5
Cardiovascular aspects of endocrine diseases
Glucocorticoid replacement-doses and cardiovascular events in autoimmune Addison's disease - a population based retrospective cohort study
ea0056oc10.1
Canagliflozin attenuates the progression of atherosclerosis via reducing hyperlipidaemia and inflammation process in ApoE KO Mice
ea0056oc10.2
ARMC5 variants and risk of hypertension in African Americans: Minority Health-GRID study
ea0056oc10.3
Improvement in the control of hypertension in diabetic patients screened for hyperaldosteronism
ea0056oc10.4
Increased risk of antithyroid drug-induced agranulocytosis with amiodarone
ea0056oc10.5
Clinical practice in endocrine tumours: combining conventional and molecular features
Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication
ea0056oc11.1
Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma
ea0056oc11.2
Clinical and histopathological differences between MEN1 carriers and MEN1 phenocopy patients
ea0056oc11.3
Update in the genetic landscape of Cushing's Disease: TP53 and a new deubiquitinase in spotlight
ea0056oc11.4
Natural history of Rathke's Cleft Cysts: a multicenter experience
ea0056oc11.5
Novel aspects of puberty development and Cushing's disease
Growth hormone signaling in leptin receptor expressing cells, but not in Kiss1 expressing neurons, regulates the timing of puberty
ea0056oc12.1
Oligogenicity in Kallmann syndrome - an underestimated phenomenon?
ea0056oc12.2
Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism
ea0056oc12.3
Late-night salivary cortisol (LNSC) levels in a Phase III study of long-acting pasireotide in patients with Cushing's disease (CD)
ea0056oc12.4
Diabetes mellitus and muscle weakness are independently associated with mortality in patients with Cushing's syndrome. Data from ERCUSYN
ea0056oc12.5
The curious case of growth hormone
Postoperative use of somatostatin analogs and mortality in patients with acromegaly
ea0056oc13.1
Time trends of mortality in patients with GH secreting and non-functioning pituitary adenoma
ea0056oc13.2
Molecular profiling for assistance to pharmacological treatment of acromegaly
ea0056oc13.3
Effects of pegvisomant on glucose metabolism in acromegaly: A meta-analysis of prospective interventional studies
ea0056oc13.4
Growth hormone acts in AgRP neurons to control energy expenditure during food restriction and promotes counter-regulatory responses to hypoglycemia via the ventromedial hypothalamus
ea0056oc13.5
What is new in gestational and type 1 diabetes?
Does insulin treatment differ in their impact on placental vascular circulation in obese and non obese women with gestational diabetes mellitus?
ea0056oc14.1
Profiling of activation patterns of placental mTOR in pregnancies complicated by gestational diabetes mellitus
ea0056oc14.2
Patrolling monocytes are activated in diabetes and provide protection to retinal vessels in the context of leukostasis
ea0056oc14.3
The variability of glycemia and the metabolic composition of brain cells in patients with type 1 diabetes mellitus
ea0056oc14.4
Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine
ea0056oc14.5
Guided Posters
Acromegaly
Retinal vessel abnormalities in acromegaly
ea0056gp2
An insight into the putative risk factors for IGF-1/GH dichotomy during follow-up for acromegaly
ea0056gp3
Efficacy and safety of switching to pasireotide LAR monotherapy or in combination with pegvisomant in acromegaly patients controlled with combination therapy of somatostatin analogues and pegvisomant (PAPE study): a prospective, open-label 48 week study
ea0056gp4
The importance of MEN1 gene variants in AIP mutation negative FIPA patients
ea0056gp5
IGF-I response to pasireotide LAR treatment in acromegaly is mainly driven by somatostatin receptor subtype 2 expression
ea0056gp6
Familial cancer clustering in patients with pituitary adenoma
ea0056gp7
ACRONIS, a European observational study in patients with uncontrolled acromegaly who are being treated with long acting pasireotide: first interim analysis
ea0056gp8
Pregnancy and acromegaly - clinical outcomes from the Irish Pituitary Network
ea0056gp9
Human growth hormone (GH) isoforms during oral glucose tolerance test in patients with acromegaly and in healthy subjects
ea0056gp10
Observational, multicentre study to evaluate the effectiveness in routine clinical practice of Lanreotide Autogel 120 mg at extended dosing intervals (>4 weeks) for the treatment of acromegaly: SOMACROL study
ea0056gp11
Cumulative effects of growth hormone and insulin-like growth factor-1 exposure on cardiovascular, cerebrovascular and metabolic co-morbidities in acromegaly patients
ea0056gp12
Adrenal Case reports
Adrenal schwannoma presenting as an adrenal incidentaloma in a pregnant woman
ea0056gp13
Sporadic paraganglioma and the importance of genetic screening
ea0056gp14
Etomidate for the management of severe hypercortisolaemia in different clinical scenarios - a case series
ea0056gp15
Pheochromocytoma associated with cutaneous and uterine leiomyomatosis and renal cancer in a patient with a germline mutation in the FH gene
ea0056gp16
A rare cause of endocrine hypertension
ea0056gp17
Bilateral testicular masses and adrenal insufficiency in a young adult: is congenital adrenal hyperplasia the only possible diagnosis?
ea0056gp18
Nonclassical congenital adrenal hyperplasia in a young patient with Type 1a Glycogen storage disease: is there a novel link between glucose metabolism and adrenal steroidogenesis?
ea0056gp19
Cushing's syndrome revealing carney complex due to novel PRKAR1A mutation
ea0056gp20
The importance of the follow-up after bilateral adrenal adenomectomy for Cushing's syndrome
ea0056gp21
Adrenal clinical
Hypoadrenalism in advanced HIV: a pilot study
ea0056gp22
Nicotinamide Nucleotide Transhydrogenase as a novel treatment target in adrenocortical carcinoma
ea0056gp23
Germline CYP2W1*6 polymorphism is a new predictive marker of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicenter European study
ea0056gp24
Metabolic fingerprints after Cushing syndrome cure
ea0056gp25
Segmental adrenal venous sampling may give a key to solution about the debate of cosyntropin stimulation or not
ea0056gp26
The short synacthen test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function and guide clinical practice
ea0056gp27
Immunohistochemical staining for histopathological subclassification of primary aldosteronism: nationwide 10-year results from Iceland
ea0056gp28
Salivary cortisol and cortisone in Cushing diagnosis - reference ranges and clinical cut off limits
ea0056gp29
The urinary cortisol metabolome in patients with adrenal insufficiency: dual-release hydrocortisone is less deleterious than conventional hydrocortisone therapy
ea0056gp30
Circular RNA circ0066659 functions as a competitive endogenous RNA by sponging miR-506-3p in adrenocortical carcinoma
ea0056gp31
Adrenal cortex
PRKACA L206R mutation in adrenal Cushing induces histone H1.4 hyper-phosphorylation
ea0056gp32
Alterations in Clock genes expression in human benign adrenal tumors
ea0056gp33
Effects of replication of the physiological and non-physiological cortisol rhythm on insulin sensitivity in muscle: a molecular in vitro analysis on synchronized muscular cells
ea0056gp34
The circadian rhythm of glucocorticoid administration entrains clock-controlled genes in blood mononuclear cells: a DREAM trial ancillary study
ea0056gp35
Identification of new ARMC5 missense mutations in Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) and their functional studies in vitro
ea0056gp36
MicroRNA expression profiling in adrenal myelolipoma, adrenocortical cancer and adrenocortical adenoma
ea0056gp37
Identification of a new target of PRKAR1A (Carney complex gene): KCTD20 (potassium channel tetramerization domain containing 20) and study of its role in adrenal Cushing
ea0056gp38
Gene mutation analysis and overal survival among the patints with neuroendocrine tumors of the lung and gastroenteropancreatic neuroendocrine tumors
ea0056gp39
Long term imaging follow-up of non-functioning adrenal adenomas at Vilnius University Hospital Santaros Klinikos (VUHSK): 2010-2017
ea0056gp40
The need for depression screening in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion - the role of integrated care
ea0056gp41
Adrenal medulla and NETs
Pituitary adenoma and pheochromocytoma/paraganglioma: a multicausal association of tumors
ea0056gp42
Ex vivo metabolomic profiling in phaeochromocytoma, paraganglioma and GIST tumours: lessons learned
ea0056gp43
Mortality in patients with Pheochromocytoma: a population-based study 1977-2016
ea0056gp44
The 10 Hounsfield Units cut-off value on unenhanced CT imaging is highly sensitive to diagnose pheochromocytoma: a multicenter study
ea0056gp45
Comparative study between incidental and symptomatic pheochromocytoma
ea0056gp46
Identifying active steroids, steroid receptors and pathways in the normal breast and their potential relationship to obesity and cancer development
ea0056gp47
In vitro studies reveal a potential therapeutic role of the combination of biguanides and statins for the treatment of prostate cancer
ea0056gp48
Targeted destruction of FSHR-positive cancer cells by a lytic Phor21-FSHb conjugate
ea0056gp49
Abstract unavailable
ea0056gp50
Evolution of mesenteric metastasis in small intestinal neuroendocrine tumours (SI-NETs)
ea0056gp51
Epidemiology and clinical significance of clinical hormonal syndromes in patients with neuroendocrine tumors
ea0056gp52
Bone and Osteoporosis
Online bots could help in prevention and treatment of osteoporosis
ea0056gp53
Effect of inhaled corticosteroidson trabecular bone score in patients with asthma
ea0056gp54
Association between diabetes and the risk of falls: a nationwide population-based study
ea0056gp55
The influence of adipose tissue and bone marrow fat on bone mineral density in short bowel syndrome
ea0056gp56
Kinesiotherapy rehabilitation program to correct deep core stability muscle dysfunction in patients with osteoporotic vertebral fractures
ea0056gp57
Investigating glucocorticoids as mediators of increased bone marrow adiposity during caloric restriction
ea0056gp58
Thirty-one men and women with145 spontaneous vertebral fractures after denosumab discontinuation: a single center observational study
ea0056gp59
Effects of anti-osteoporotic medications on glucose metabolism and the incidence of type 2 diabetes mellitus: a systematic review
ea0056gp60
Bone structural components and lean mass assessed by 3D-DXA in hip fracture patients
ea0056gp61
Inflammatory profile in monocytes of patients with Addison's disease and Vitamin D effects
ea0056gp62
Cardiovascular
OCT1 gene variants are associated with cardiovascular characteristics in non-diabetic, prediabetic and diabetic patients
ea0056gp63
Habitual dietary intake of n-3 polyunsaturated fatty acids and leptin gene expression in visceral and subcutaneous adipose tissues of non-diabetic adults
ea0056gp64
Decreased heart rate variability can predict future development of metabolic syndrome in Asian adults
ea0056gp65
Evaluation of irisin levels in chronic heart failure with preserved or reduced ejection fraction
ea0056gp66
Liraglutide prevented the deposition of Collagen in the animal model of Bleomycin-induced lung fibrosis
ea0056gp67
Turner syndrome and cardiovascular risk
ea0056gp68
Can monogenic severe hypertriglyceridemia be differentiated from polygenic forms through clinical features: data from APPROACH and COMPASS studies in FCS and non-FCS hypertriglyceridemic patients?
ea0056gp69
Changes in lipid profile 5 years after bariatric surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy
ea0056gp70
Diabetes Complications
Prevalence and risk factors of periodontitis in diabetic patients with or without metabolic syndrome
ea0056gp71
Toe-brachial index is associated more strongly with progression of diabetic nephropathy than ankle-brachial index in type 2 diabetic patients
ea0056gp72
The BMI and skeletal muscle mass as a risk factor of carotid atherosclerosis in patients with type 2 diabetes
ea0056gp73
Is liver stiffness associated with diabetic complications in patients with type 2 diabetes and non-alcoholic fatty liver disease?
ea0056gp74
Effects of post-transplant and pre-existing diabetes mellitus on graft function after kidney transplantation
ea0056gp75
Glucose variability and pregnancy outcomes in gestational diabetes mellitus: a prospective study
ea0056gp76
Patients with community acquired pneumonia are three times more likely to die if they have concomitant diabetes mellitus
ea0056gp77
Diabetic patients are old as theirs feet are old:the strongest association of foot pathology with mortality in diabetes
ea0056gp78
Outcomes of hyperglycemia in patients with and without diabetes mellitus hospitalized for infectious diseases
ea0056gp79
Self-reported low-energy fractures and associated risk factors in diabetic portuguese patients: a cross-sectional population-based study
ea0056gp80
Impaired cortisol and growth hormone counterregulatory responses during severe hypoglycemia in type 2 diabetes mellitus
ea0056gp81
Diabetes Epidemiology
Maternal exposure to air pollutants and risk of gestational diabetes mellitus in Taiwan
ea0056gp82
Prevalence and predictors of gestational diabetes mellitus: a nationwide multicenter prospective study
ea0056gp83
Incretin hormones in pathogenesis of secondary hyperglycaemia in patients with Cushing's disease and acromegaly
ea0056gp84
Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
ea0056gp85
Heart rate variability is related to concomitant glucose fluctuation in longstanding type 1 diabetes
ea0056gp86
Differential expression of apoptotic and low grade inflammatory markers in Alzheimer's disease compared to diabetes mellitus type 1 and 2
ea0056gp87
Gestational diabetes mellitus and continuous glucose monitoring system. A prospective study.
ea0056gp88
Depression screening in adults with diabetes
ea0056gp89
Nutritional composition of carbohydrate-rich gluten free products and glycemic index calculation of commercially available gluten free pasta
ea0056gp90
Analysis of health-related quality of life in patients with type 2 diabetes mellitus: results of an epidemiological study FORSIGHT-T2DM
ea0056gp91
Gestational Diabetes Mellitus is associated with increased risk of Non-Alcoholic Fatty Liver Disease: A population-based cohort study
ea0056gp92
Diabetes Therapy
Proinflammatory cytokines and endotoxemia level change in patients with type 2 diabetes and nonalcoholic fatty liver disease after hepatoprotective and probiotic therapy usage
ea0056gp93
Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-center Randomized Controlled Trial
ea0056gp94
Randomized control study to compare security and efficacy of the new long acting analogues degludec and glargina U300 in people with type 1 Diabetes. Preliminary results of the Ineox study
ea0056gp95
Long term results and determinants of outcomes in primary health care diabetes prevention. The DE-PLAN project
ea0056gp96
Comparison of insulin degludec with Insulin glargin 300 units/ml in insulin-naive patients with type 2 diabetes mellitus
ea0056gp97
Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation
ea0056gp98
Optimal time for measuringglucose level to detect steroid induced hyperglycaemia
ea0056gp99
Effect of aerobic exercise training on serum malondialdehyde level and quality of life in type 2 diabetes
ea0056gp100
A healthier fat intake is associated with absence of diabetic retinopathy in patients with type 1 diabetes
ea0056gp101
Type 2 diabetes remission one year after bariatric surgery - a comparison between vertical sleeve gastrectomy and gastric bypass
ea0056gp102
Glycemic control and outcomes of patients admitted in the acute stroke unit
ea0056gp103
Validation of Friedewald formula for estimatinglow-density lipoprotein cholesterol in Korea: the Korea National Health and Nutrition Examination Survey, 2009-2011
ea0056gp104
Diabetes Translational
Acute insulin-induced hypoglycemia decreases systemic fibrinolytic balance in patients with type 1 diabetes
ea0056gp105
Transcranial duplexsonography in patients with type 1 diabetes and diabetic nephropathy
ea0056gp106
Cumulative effect of glucose regulation in Calbindin-D9k knockout mice
ea0056gp107
The effect of GLP-1 agonist treatment on serum betatrophin levels and comparison with insulin treatment in type 2 diabetes mellitus patients
ea0056gp108
High glucose stimulates mineralocorticoid receptor activity of retinal Muller glia cell
ea0056gp109
Knock-down of class 2a histone deacetylases (HDACs) in hepatocytes of healthy mice does not affect gluconeogenesis but is associated with increased hematopoiesis
ea0056gp110
Olfactory receptor OR51E1 mediates GLP-1 secretion in enteroendocrine L cells
ea0056gp111
Study on antioxidant and hypoglycemic effects of natural polyphenols in the experimental diabetes model
ea0056gp112
Diazoxide pretreatment improves pancreatic islet survival in vitro and functionality in vivo
ea0056gp113
Benefits of the association of triiodothyronine (T3) to insulin treatment for the glycemic control of alloxan-induced diabetic rats
ea0056gp114
Male AKR1D1 (5[beta]-reductase) knockout mice have altered pancreatic islet morphology and hormone secretion
ea0056gp115
The role of oncostatin m in the development of type 2 diabetes associated with obesity
ea0056gp116
Endocrine Case Reports
A rare case report of Graves disease with coexisting TSH producing pituitary adenoma
ea0056gp117
Abstract unavailable
ea0056gp118
Non-syndromic multiple insulinomas with atypical clinico-biological presentation in two adult patients: a specific entity?
ea0056gp119
Langerhans cell histiocytosis: diagnosis on thyroid aspirate
ea0056gp120
Coexistence of papillary thyroid cancer and malignancies of other organs in patients carrying CHEK2 gene mutations - case series.
ea0056gp121
A case of nivolumab induced fulminant type 1 diabetes
ea0056gp122
A rare case of type-2 familial partial lipodystrophy (FLD type 2) non-Dunnigan type with laminin A/C gene (LMNA) mutation causing multi-organ failure and diabetes mellitus
ea0056gp123
MODY - a diagnosis to be considered in diabetes
ea0056gp124
Hyperinsulinaemic hypoglycaemia in the three generations of a family with GCK, c.295T>C (p.Trp99Arg) mutation
ea0056gp125
Acromegaly and acromegaloidism, two rare insulin-resistance conditions in one patient: reason for GH-IGF-1 discrepancy?
ea0056gp126
Female Reproduction
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
ea0056gp127
Low-dose SKA Progesterone and Interleukin-10 modulate the inflammatory pathway in endometriotic cell lines
ea0056gp128
Impaired GLP-1 response predicts prediabetes in obese PCOS with adverse metabolic phenotype independent of BMI
ea0056gp129
Alterations in gonadotropin receptors and signal activation in granulosa lutein cells from women with polycystic ovary syndrome
ea0056gp130
Prevalence of mutations in the insulin receptor gene and lamin A/C gene in functional ovarian hyperandrogenism with insulin resistance
ea0056gp131
Women with PCOS display reduced cardiac vagal activity which is dependent on metabolic abnormalities
ea0056gp132
Favorable prognosis of pregnancies in 28 hypopituitary women: Retrospective multicentric study on 39 pregnancies
ea0056gp133
Abstract unavailable
ea0056gp134
Liquid chromatography-tandem mass spectrometry characterization of a broad serum and salivary steroid profile in classical form of polycystic ovary syndrome
ea0056gp135
Novel mechanisms and genes involved in the pathogenesis of primary ovarian insufficiency (POI) by whole-exome sequencing approach
ea0056gp136
Hypothalamo-pituitary-adrenal axis sensitivity in women with polycystic ovary syndrome
ea0056gp137
Neuroendocrinology
Hypermethylation of tumour suppressor genes in pituitary adenomas: contribution to oncogenesis and tumour behaviour
ea0056gp138
Why don't corticotroph tumours always produce Cushing disease?
ea0056gp139
New horizons in medical treatment of Bronchial Carcinoids: evidence from in vitro models
ea0056gp140
Reproductive and metabolic consequences of AMP-Activated Protein Kinase (AMPK) ablation in GnRH neurons
ea0056gp141
Preoperative SSA treatment positively affects the outcome of pituitary neurosurgery in acromegaly patients
ea0056gp142
Characterization and functional rescue of a nephrogenic diabetes insipidus causing S127F substitution in V2 vasopressin receptor
ea0056gp143
Genetics of binge-eating disorder (BED): a pilot study
ea0056gp144
Hyponatremia-associated mortality and volemia in patients on parenteral nutrition: a prospective multicenter study
ea0056gp145
Hyperglycemia causes a reduction in FSH levels following aberrant epigenetic regulation in the gonadotropes due to the increased glucose metabolism
ea0056gp146
Macrophages involvement in neuroendocrine tumor behaviour and progression
ea0056gp147
Mountain cycling ultramarathon effects on neuromuscular, immune and stress biomarkers
ea0056gp148
Obesity
Sex hormone-binding globulin is more than a sex steroid carrier: a New therapeutic target against obesity and non-alcoholic fatty liver disease
ea0056gp149
Use of ultrasonography as a simple diagnostic method to measure different abdominal fat layers and metabolic syndromeprediction
ea0056gp150
Improvement in insulin-mediated suppression of branched-chain amino acid flux is responsible for the post-bariatric surgery decrease in plasma branched-chain amino acid levels
ea0056gp151
Cell-derived extracellular vesicles as important intercellular messengers in obesity
ea0056gp152
How to better predict weight loss and type 2 diabetes remission after bariatric surgery? the potential role of genetic scoring systems in clinical practice
ea0056gp153
Eating and substance-related disorders after bariatric surgery
ea0056gp154
Changes in gut microbiota and metabolic profiles after sleeve gastrectomy
ea0056gp155
Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis
ea0056gp156
Obesity is associated with a dysregulation in the splicing machinery components at the hepatic level: influence of metformin
ea0056gp157
Dietary intake of fat and oil are associated with expression of miR-143 and miR-34a in visceral and subcutaneous adipose tissues of adults: a nutriepigenetic study
ea0056gp158
Role of Elovl6 in the thermogenic action of brown and beige adipocyte during [beta]3-adrenergic receptor activation
ea0056gp159
Physiological regulation of brown adipose tissue in obesity by mild-cold exposure, a B3-agonist and exercise training at thermoneutrality
ea0056gp160
Cold induced thermogenesis is influenced by seasonal changes in outdoor temperature
ea0056gp161
Paediatrics, Developmental ' Female Reproduction
Biomonitoring infantile urinary sexual hormone profiles for investigation of the endocrine disruptors associated mini-puberty effects
ea0056gp162
Global DNA methylation since early infancy to adulthood in the offspring of women with polycystic ovary syndrome (PCOS)
ea0056gp163
Utilisation of dental services and dental pathologies identified in children and adolescents with osteogenesis imperfecta in the south west of England
ea0056gp164
Early childhood BMI rise, the adiposity rebound, associates with PCOS diagnosis and obesity at ages 31 and 46 years - analysis of 46-year growth data from birth to adulthood in PCOS
ea0056gp165
Endemic goiter and breasts diseases in adolescent girls
ea0056gp166
Impact of fetal exposure to testosterone on fetal insulin sensitivity tissues in female sheep: a morphological and molecular approach
ea0056gp167
Self-esteem, emotional stability, social anxiety disorder and suicidal behaviours among transgender youth before gender-affirmative treatment in spain
ea0056gp168
Glucose transporters in human placenta and its relation to birth weight
ea0056gp169
Association of glucocorticoid receptor gene (NR3C1) expression in HUVECs with glycemic targets during gestational diabetes treatment: a pilot randomized controlled study
ea0056gp170
Autoimmunity markers in turner syndrome patients
ea0056gp171
Parathyroid
A pilot study of the differences in miRNA expression profile in the blood serum between patients with malignant and benign parathyroid tumors
ea0056gp172
Excess of parathyroid hyperplasia incidence in subjects exposed to ionizing radiation after the CHNPP accident
ea0056gp173
The design and preliminary results of a phase 1 TransCon PTH trial in healthy volunteers
ea0056gp174
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement
ea0056gp175
Symptom burden and HRQoL reported among patients with chronic hypoparathyroidism: impact of treatment with rhPTH (1-84) and with standard therapy
ea0056gp176
Maintenance of key biochemical parameters with recombinant human parathyroid hormone (1-84) in patients with hypoparathyroidism: an analysis of a long-term, open-label, single-centre study
ea0056gp177
The global, prospective, observational PARADIGHM registry for patients with chronic hypoparathyroidism was expanded to capture recombinant human parathyroid hormone, rhPTH(1-84), use under routine clinical care
ea0056gp178
Stone risk profile analysis in patients with asymptomatic primary hyperparathyroidism
ea0056gp179
Five-year efficacy and safety of recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) for the treatment of adults with chronic hypoparathyroidism: analysis from the open-label race study
ea0056gp180
Is there HIV-associated hypoparathyroidism?
ea0056gp181
Use of a Disease-Characteristic Questionnaire identified pain and cramps and neuro-vegetative symptoms as significantly elevated and affected by Medication in mainly well-controlled hypoparathyroid patients
ea0056gp182
A novel mutation in the calcium sensing receptor GENE IN AN Italian family affected by autosomal dominant hypocalcemia
ea0056gp183
Pituitary / Growth Hormone ' IGF Axis
Adrenal insufficiency induced by anti-PD-1/anti-PD-L1 therapy in patients with cancer: a series of cases
ea0056gp184
Long-term treatment with metyrapone in four patients with Cushing's disease
ea0056gp185
Primary posterior pituitary tumors: a unique neoplasm with hight morbidity
ea0056gp186
Erdheim-chester disease presenting with hypopituitarism and diabetes insipidus
ea0056gp187
Growth disorders in paediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning- the experience of a single center
ea0056gp188
Association of IGF1 receptor autoantibodies with height and body size
ea0056gp189
Insulin sensitivity improves after disease control in acromegaly irrespective of treatment modality and despite an increase in intrahepatic lipid content: data from an investigator-initiated prospective trial
ea0056gp190
Ectopic Cushing's syndrome secondary to medullary thyroid carcinoma with apparent signs of hypercortisolism: a case report
ea0056gp191
A case series of endocrine immune-related adverse effects of checkpoint inhibitors
ea0056gp192
Hypophysitis due to immune checkpoint blockade: rising numbers.
ea0056gp193
Pituitary Basic
Olfactory marker protein regulates prolactin secretion and production by modulating Ca2+ and TRH signaling in lactotrophs
ea0056gp194
Filamin A (FLNA) phosphorylation inhibits SSTR2 signal transduction in GH-secreting pituitary tumor cells
ea0056gp195
E-cadherin expression is associated with the response to somatostatin analogues in patients with acromegaly
ea0056gp196
Efficacy of pharmacological USP8 inhibition in human Cushing's disease tumours in vitro
ea0056gp197
Ubiquitin specific peptidase 8 (USP8) in human corticotroph pituitary tumors- possible targets and mode of action
ea0056gp198
Prominent expression of MAX and MEG3, despite lack of mutations in MAX, suggest a potential role for 14q genes in pituitary adenomas
ea0056gp199
Pharmacological characterization of somatostatin receptor subtype 3 as a potential strategy to treat non-functioning pituitary adenomas
ea0056gp200
Epigenetic and post-transcriptional regulation of the SSTR5 gene in somatotropinomas
ea0056gp201
Pituitary Clinical
Endoscopic vs microscopic transsphenoidal surgery for Cushing's disease: a systematic review and meta-analysis
ea0056gp202
Factors predicting comorbidities in cured patients with Cushing's syndrome
ea0056gp203
Long-term efficacy and safety of once-monthly pasireotide in patients with Cushing's disease: A Phase III extension study
ea0056gp204
Predictors of response to long-acting pasireotide in patients with Cushing's disease during a Phase III study
ea0056gp205
Clinicopathological correlations in pituitary thyrotroph tumors from a cohort of 23 patients
ea0056gp206
Molecular profiling of non-functioning pituitary adenomas does not support pharmacological therapeutic options
ea0056gp207
The role of clomiphene citrate in the resolution of hypogonadism in male patients with prolactinomas under cabergoline therapy
ea0056gp208
Cabergoline - therapy for 121 giant invasive prolactinomas
ea0056gp209
Endocrine disorders in adults after allogenic hematopoietic stem cell transplant
ea0056gp210
A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors
ea0056gp211
Predictors of failure to respond to fluid restriction and furosemide efficacy prediction in patients presenting Syndrome of Inappropriate Antidiuretic while receiving parenteral nutrition. Prospective Multicenter Study
ea0056gp212
Abstract unavailable
ea0056gp213
Reproduction
Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management
ea0056gp214
Alleviation of perfluorooctanesulfonate (PFOS)-induced disruption of blood-testis barrier by altering cell signaling molecule expression in human sertoli cells.
ea0056gp215
Sertoli cell-specific knockout of coxsackie and adenovirus receptor (Cxadr) disrupts the blood-testis barrier and causes impaired fertility
ea0056gp216
The first Belgian series of 56 patients with congenital hypogonadotropic hypogonadism (CHH): genetic and brain abnormalities
ea0056gp217
Bioassay-based characterization of novel androgens
ea0056gp218
Mitochondrial phenotype of FOXL2 variants associated with Blepharophimosis, Ptosis and Epicantus Inversus Syndrome (BPES)
ea0056gp219
Depletion of the primate-specific luteinizing-hormone receptor splice variant 'exon-6A' impairs LH-, but not hCG-mediated signaling in human primary granulosa cells
ea0056gp220
The value of androstenedione and DHEA-S levels in diagnosis of polycystic ovary syndrome in young women
ea0056gp221
Change in visceral fat and its relation with change in lipids in trans persons during hormonal therapy: results from a multicenter prospective study
ea0056gp222
GHR ablation in the brain or in leptin receptor expressing cells causes metabolic effects during pregnancy
ea0056gp223
Thyroid Cancer - Diagnostics & Treatments
Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer
ea0056gp224
Germline mutations in KIF1B gene in two families with familial non-medullary thyroid cancer (FNMTC)
ea0056gp225
Significant acceleration in dynamics of medullary thyroid cancer markers concentration - report of 26 cases
ea0056gp226
The adverse effect of radioactive iodine therapy on bone marrow for differentiated thyroid cancer patients
ea0056gp227
Familial non-medullary thyroid carcinoma. Are we facing a different entity?
ea0056gp228
Is thyroid nodule size a factor to consider when deciding for fine-needle aspiration procedure?
ea0056gp229
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
ea0056gp230
Related recurrence factors in a Spanish cohort of differentiated thyroid carcinoma. Cadit-CAM Study
ea0056gp231
Imaging in clinical research devoted to medullary thyroid carcinoma: a systematic meta-analysis
ea0056gp232
Molecular profiling of a large papillary thyroid cancer series followed at a single center: data on mutation density, heterogeneity and phenotype-genotype correlations
ea0056gp233
Title Evaluation of the CCK-2-receptor agonist 177Lu-PP-F11N for peptide receptor radionuclide therapy (PRRT) of medullary thyroid carcinoma - First results of a phase 0 'Lumed' Study
ea0056gp234
Does body mass index influence the clinical stage, treatment response and course of the disease in patients with differentiated thyroid cancer?
ea0056gp235
Thyroid Cancer - Translational
Neural stem cells expressing cytosine deaminase and interferon-[beta] suppressed the growth and metastasis of anaplastic thyroid cancer cells
ea0056gp236
Comparison in survival of the seventh and eighth editions of the American Joint Commision on Cancer in a Spanish cohort of differentiated thyroid carcinoma: Cadit-CAM Study
ea0056gp237
Carrying mutations truncating CHEK2 protein predisposes to thyroid neoplasms - preliminary report
ea0056gp238
The capability of the Bethesda System Reporting for Thyroid Cytopathology (TBSRTC) in identifying of thyroid carcinoma
ea0056gp239
Orthotopic PDX Mouse Model of humanprimary Undifferentiated/Anaplastic thyroid carcinoma
ea0056gp240
Detection of lncRNAs in thyroid nodule as new tool for tumor diagnosis: analysis by Droplet Digital PCR in Fine Needle Aspiration biopsy
ea0056gp241
New markers of follicular thyroid cancer found with wide-panel next-generation sequencing
ea0056gp242
Prognostic value of N0 classification in differentiated thyroid cancer
ea0056gp243
Implementation of the British Thyroid Association thyroid nodule classification: a general UK hospital perspective
ea0056gp244
Dynamic risk stratification in the follow-up of children and adolescents with differentiated thyroid cancer
ea0056gp245
Thyroid non cancer
Genistein Increase Thyroid Hormone and 7 alpha-hydroxycholesterol concentrations in the liver of middle-aged male rats
ea0056gp246
Serum FT4 levels predict incidence of type 2 diabetes and cardiovascular disease in the general population
ea0056gp247
Thyroid function in early-treated adult PKU patients
ea0056gp248
Abnormal thyroid enzymes in critically ill patients with no known prior thyroid disorder are an independent predictor of mortality
ea0056gp249
Assessment of carotid intima-media thickness and endothelial dysfunction in patients with hypothyroidism
ea0056gp250
Thyroid-specific mitochondrial dysfunction results in abnormal thyrotropin responses
ea0056gp251
T3 enhances GLUT2, PEPT1 and CD36/SR-B2 content in the intestinal epithelium of mice
ea0056gp252
Identification of new thyroid hormone dependent biomarkers for a successful replacement therapy
ea0056gp253
Proteome analysis of 3,5-T2-treated primary mouse hepatocytes
ea0056gp254
Thyroid non cancer - Autoimmune Thyroid disease/pregnancy
MicroRNA-4443 causes CD4+T cells dysfunction by targeting TRAF4 in Graves' disease
ea0056gp255
Are Thyrotropin Receptor Antibodies (TRAb) being used to diagnose the aetiology of hyperthyroidism?
ea0056gp256
Impact of TSH during the first trimester of pregnancy in obstetric and fetal complications: Usefulness of 2.5 mIU/l cut-off value
ea0056gp257
Influence of levothyroxine treatment in pregnant women with thyroid antiperoxidase antibodies
ea0056gp258
Thyroid disorders in patients with advanced neoplastic disease treated with immune checkpoints inhibitors
ea0056gp259
Early low dose rituximab for active thyroid eye disease: an effective and well tolerated treatment
ea0056gp260
Analysis of serum immunoglobulin G4 (IgG4) levels in euthyroid subjects with autoimmune thyroid disease and goiter in a Single Medical Center in Taiwan
ea0056gp261
Thyroid disorders in patients treated with inmune checkpoint inhibition therapy
ea0056gp262
Thyroid peroxidase antibody-positivity, but not isolated thyroglobulin antibody-positivity, is associated with non-thyroidal autoimmune diseases - a population study of more than 8000 Danes
ea0056gp263
Thyroid function in pregnant women; relation to Gestational Diabetes Mellitus (GDM) and Body Mass Index (BMI)
ea0056gp264
Thyroid non cancer - Benign Thyroid disease/ treatment
Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules
ea0056gp265
Radiofrequency ablation for benign symptomatic thyroid nodules: evaluation of clinical efficacy
ea0056gp266
Abstract unavailable
ea0056gp267
Response to Liothyronine therapy: Efficiacy of therapy and assessment of biochemical and physiological predictors
ea0056gp268
Tailored thyroxine treatment and gastric acid output in humans
ea0056gp269
Body composition changes during treatment of severe thyroid disorders. Is it always fat?
ea0056gp270
Personalised euthyroid targets based on a deterministic mathematical model
ea0056gp271
US-guided percutaneous microwave ablation for benign thyroid nodules: a prospective multicenter study
ea0056gp272
Abstract unavailable
ea0056gp273
Reduced quality of life and persistent complaints in treated hypothyroid patients
ea0056gp274
Poster Presentations: Adrenal and Neuroendocrine Tumours
Adrenal cortex (to include Cushing's)
Congenital adrenal hyperplasia in lady with severhirsutism and virilization due to 3B-hydroxysteroid dehydrogenase deficiency
ea0056p1
Endogenous stimulation in adrenal venous sampling (AVS) in differential diagnosis of primary hyperaldosteronism (PA)
ea0056p2
Congenital adrenal hyperplasia in 46xx male
ea0056p3
Diagnostic difficulties of Pseudo-Cushing states in women: about 24 cases
ea0056p4
Abstract unavailable
ea0056p5
Is adrenocortical carcinoma in children a different spectrum?
ea0056p6
Travelling distance and support group participation in patients with chronic adrenal insufficiency
ea0056p7
Abstract unavailable
ea0056p8
Evaluation of tumor size and hormonal status of elderly with adrenal incidentaloma
ea0056p9
Evaluation of adrenal function in Cushing's syndrome model rats
ea0056p10
Does Hemodialysis (HD) affect the overall testosterone (T) and luteinizing hormone (LH) levels in T-treated hypogonadal Congenital Adrenal Hyperplasia (CAH) male with associated chronic kidney disease (CKD)? A pilot single center matched case report
ea0056p11
A rare case of Cushing's syndrome due to adrenal adenoma complicated by familial adenomatous polyposis
ea0056p12
Hypoglycemic coma as first manifestation of primary adrenal insufficiency in a septic patient with severe hypokalemia and hypomagnesemia
ea0056p13
Preoperative treatment with metyrapone in patient with Cushing's syndrome due to adrenal adenoma: a pilot prospective study
ea0056p14
Clinical features of adrenal incidentalomas
ea0056p15
Rare incidence of primary adrenocortical carcinosarcoma: a case report
ea0056p16
Clinical and biochemical outcomes in surgically treated patients with primary aldosteronism. A multicentric retrospective study
ea0056p17
Intraoperative hypertensive crisis as a key symptom in a normotensive patient with primary aldosteronism - clinical case
ea0056p18
Adrenal insufficiency during prednisolone treatment in patients with polymyalgia rheumatica or giant cell arteritis - prevalence and clinical approach
ea0056p19
Prevalance of primary aldosteronism in hypertensive patients: epidemiological data from a tertiary centre
ea0056p20
Renin: a possible novel marker for the efficacy of pharmacological treatment of primary aldosteronism
ea0056p21
Conn Syndrome Presented with Muscle Weakness
ea0056p22
Large Oncocytic Adrenocortical Tumor with Uncertain Malignant Potential
ea0056p23
Conjugated steroids could be a reserve stock for rapid conversion into free ones during stress
ea0056p24
Presence of comorbidities related to hypercortisolism in a case series on adrenal incidentaloma (AI)
ea0056p25
Increased levels of Interleukin-6 in patients with primary and secondary hypocortisolism: A case-control study
ea0056p26
A new ARMC5 mutation responsible for primary bilateral macronodular adrenal hyperplasia
ea0056p27
Abstract unavailable
ea0056p28
Secondary adrenal insufficiency - is not this diagnosis often made too hasty?
ea0056p29
Assessing the new Primary Aldosteronism guidelines recommendation to omit confirmatory testing in selected patients - severity of hypokalaemia may be included
ea0056p30
Addison's disease due to adrenal tuberculosis: A case report
ea0056p31
How can cortisol-normalized adrenal venous sampling miss some Conn's adenoma
ea0056p32
ACTH stimulation test for study of primary aldosteronism
ea0056p33
Value of 131I-Norcholesterol scintigraphy in the evaluation of primary hyperaldosteronism
ea0056p34
A four months infant survival case of waterhouse-friderichsen syndrome
ea0056p35
Hypoaldosteronism induced by trimethroprim: hyponatremia is frequent
ea0056p36
Utility of adrenal venous sampling for the differential diagnosis of primary hyperaldosternoism subtypes
ea0056p37
Non-classic congenital adrenal hyperplasia clinics characteristics and treatment response cohort study
ea0056p38
A rare incidentaloma: adrenal schwannoma
ea0056p39
Cardiovascular risk in patient with incidentally detected adrenal masses - associated with metabolic syndrome and hypercortcism
ea0056p40
Outcomes of patients undergoing surgery for primary aldosteronism based on adrenal venous sampling and/or radiological lateralisation indicate a role for both modalities in case selection
ea0056p41
The response of C19- Δ5-steroids to ACTH stimulation
ea0056p42
Non-classical form of congenital adrenal hyperplasia in patients with bilateral incidentalomas - hormonal and genetic analysis
ea0056p43
Adrenal insufficiency in treated PMR: The tip of the iceberg
ea0056p44
Decreased quality of life in male patients with primary adrenal insufficiency of Indian origin
ea0056p45
The measurement of the renin-angiotensin-aldosterone system in patients with adrenal tumors with arterial hypertension
ea0056p46
The renin-angiotensin-aldosteron system in primary adrenal insufficiency
ea0056p47
Percutaneous microwave ablation of adrenal remnant tissue. A novel treatment modality for persistent Cushing's disease
ea0056p48
Risk estimator for autonomous cortisol secretion in adrenal incidentalomas. Retrospective study of 100 cases
ea0056p49
Is the adrenal vein sampling the gold standard diagnostic test for the subtyping of primary aldosteronism?
ea0056p50
A descriptive study of patients with adrenocortical carcinoma treated in hospital clinico san carlos (HCSC) over the last 20 years
ea0056p51
Bilateral adrenalectomy for occult ectopic Cushing's syndrome in two patients with catastrophic hypercortisolism
ea0056p52
In vitro effects of KCNJ5 mutations on cellular death mechanisms
ea0056p53
The role of DHEAS in the diagnosis of possible autonomous cortisol secretion by incidentally discovered adrenal adenomas
ea0056p54
Abnormal salivary cortisol result in patient with low probability of Cushing disease
ea0056p55
Improved salivary cortisol rhythm with dual-release hydrocortisone
ea0056p56
A case of adrenal Cushing's syndrome initially presenting with diabetic ketoacidosis
ea0056p57
The diagnostic accuracy of increased late night salivary cortisol for Cushing's Syndrome: a real-life prospective study
ea0056p58
Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas
ea0056p59
Expert patients are better prepared to survive adrenal crisis than most - but still lack training in injection method
ea0056p60
Histopathological characteristics of lipid-poor adrenal adenomas
ea0056p61
Different biological and functional features in patients with Cushing's disease harboring micro- or macro-adenomas
ea0056p62
Salivary cortisol as a diagnostic tool for hypercortisolism in Cushing's syndrome and adrenal incidentaloma
ea0056p63
Bilateral macronodular adrenal hyperplasia with autonomous cortisol secretion
ea0056p64
A systematic survey of low S-cortisol levels at the department of clinical chemistry: indications for testing and frequency of undiagnosed adrenal insufficiency
ea0056p65
Evaluation of cardiometabolic profile of patients submitted to unilateral adrenalectomy
ea0056p66
Adrenal venous sampling in patients with ACTH-independent Cushing's syndrome
ea0056p67
Association of the BclI glucocorticoid receptor polymorphism with metabolic parameters in female patients with adrenal incidentalomas
ea0056p68
Adrenocortical carcinoma in the experience of one clinical center
ea0056p69
Adrenocortical carcinoma: retrospective analysis of a series of clinical cases
ea0056p70
Adrenal medulla
Imaging characteristics of pheochromocytomas
ea0056p71
Genetics in pheochromocytoma and paraganglioma: a case series
ea0056p72
Analysis of a pheochromocytoma case series over 12 years: a specialty hospital experience
ea0056p73
Laparoscopic surgery for pheochromocytoma: perioperative outcomes
ea0056p74
Malignant pheochromocytoma discovered upon consultation for painful erections
ea0056p75
Can patients with a large sporadic pheochromocytoma and very high norepinephrine secretion be normotensive? Yes, they can!
ea0056p76
Pheochromocytoma revelation modalities: about 23 cases
ea0056p77
When the large tumor is not the first intention for removal-concomitant discovery of left adrenal pheochromocytoma and a possible retroperitoneal plexiform neurofibroma in a case of familial neurofibromatosis type 1- case report
ea0056p78
Why is it important to screen secondary endocrine hypertension in resistant cases? Lessons from a patient with progressive renal failure
ea0056p79
Association of pheochromocytoma and neurofibrematosis type1: about 4 cases
ea0056p80
A retrospective audit on the peri-operative management of phaeochromocytomas: [ldquo]Phenoxybenzamine or Doxazosin[rdquo]?
ea0056p81
Calcium ' Vitamin D metabolism
25-OH vitamin D concentration and inflammation indicators in patients with non-functioning adrenal incidentalomas
ea0056p82
Cardiovascular Endocrinology and Lipid Metabolism
Arterial hypertension from the adrenal gland: Prognosis and predictive factors of recovery after chirurgical treatment
ea0056p83
Metabolic and hormonal profile in primary aldosteronism as compared with essential hypertension
ea0056p84
Aortic root dilatation in primary aldosteronism: is treatment effective in reducing aortic damage?
ea0056p85
Clinical case reports - Pituitary/Adrenal
Abstract unavailable
ea0056p86
Long-term follow-up of congenital adrenal hyperplasia due to 11[beta]-hydroxylase deficiency
ea0056p87
Rhabdomyolysis in a case with severe hypokalemia and Primary Hyperaldosteronism
ea0056p88
Pheochromocytoma in young patient-challenges in clinical practice
ea0056p89
Opioid-induced secondary adrenal insufficiency
ea0056p90
Intracerebral hemorrhage as a first sign of pheochromocytoma
ea0056p91
Severe pheochromocytoma crisis, Type B, resulting in Takotsubo-like cardiomyopathy and fulminant refractory cardiogenic shock, successfully treated with extracorporeal membrane oxygenation (ECMO) but with fatal neurological sequelae for the patient.
ea0056p92
Functionig adrenal incidentaloma false positive for 18F-FDG-PET/TAC
ea0056p93
Difficult Management of Autoimmune Polyglandular Syndrome Type 1
ea0056p94
Pitfalls in differential diagnosis of adrenal masses
ea0056p95
From gastric sleeve to diagnosis of a rare familial multiple endocrine neoplasia type 1
ea0056p96
Primary adrenal lymphoma in an HIV patient: a rare case of bilateral adrenal tumors
ea0056p97
High Adrenocorticotropic Hormone before and after bilateral adrenal surgery
ea0056p98
Addison's disease due to bilateral adrenal hemorrhage as the first presentation of diffuse large B-cell lymphoma
ea0056p99
17- [alpha] hydroxylase deficiency in an adult female patient with hypertention and hypokalemia
ea0056p100
Li-Fraumeni syndrome and adrenal tumours: case report
ea0056p101
Addison's disease due to bilateral adrenal hemorrhage as the firstpresentation of diffuse large B-cell lymphoma
ea0056p102
Paraganglioma of the prostate: a case report
ea0056p103
A new gene - TMEM127 - in familial pheochromocytoma/paraganglioma syndromes
ea0056p104
Bilateral adrenal mass revealing a pheochromocytoma and an adrenocortical adenoma in a young women: a case report
ea0056p105
Cushing's syndrome in a patient with systemic lupus erythematosus
ea0056p106
Clinical case reports - Thyroid/Others
Searching for the cause of high HCG in a man
ea0056p107
Syndrome carney-stratakis, new mutation report: SDH B: D138Y (c.412>T)
ea0056p108
Challenges in the diagnosis and treatment of GEP NEN: a case report
ea0056p109
Endocrine tumours and neoplasia
Ectopic adrenocorticotropic hormone syndrome: clinical features, diagnosis, treatment and long-term observation. Impact of bronchial carcinoid tumors
ea0056p110
Effect of 177 Lu-dotatate on severe, life-threatening, and refractory hypoglycemia associated with malignant insulinoma
ea0056p111
Morphological changes of the adrenal glands with hypertension with a crisis current
ea0056p112
Atypical manifestation of adrenocortical carcinoma - case series
ea0056p113
Are there any clinical predictor for malignancy in malignant pheochromocytoma?
ea0056p114
New cancer drug targets identified in adrenocortical carcinoma through gene expression profiling
ea0056p115
Outcome of adjuvant mitotane therapy in patients with adrenocortical carcinoma: the experience of San Luigi Gonzaga Hospital
ea0056p116
Adrenocortical carcinoma - characteristics and outcome of patients treated at Helsinki University Hospital during the last 15 years
ea0056p117
Comparative study between familial and sporadic pheochromocytoma
ea0056p118
Clinical features, management and outcomes of adrenocortical carcinoma: a case series analysis
ea0056p119
A case of multiple endocrine neoplasia type 1 (MEN1) with non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) responding to medical treatment with diazoxide
ea0056p120
A case of benign insulinoma successfully treated with endoscopic ultrasound guided radiofrequency ablation
ea0056p121
Careful selection of patients with primary aldosteronism using combination of age, serum potassium and CT adrenal glands can avoid the need for adrenal venous sampling prior to adrenalectomy.
ea0056p122
Hormonal secretion prevalence in a series of subjects with adrenal tumors incidentally discovered in clinical practice
ea0056p123
Genetic background as a predictive factor of pheochromocytoma and paraganglioma presentation
ea0056p124
Heterogeneous genetic background of Hungarian patients with pheochromocytoma/paraganglioma requires gene panel testing
ea0056p125
Gastroenteropancreatic neuroendocrine tumors are predictive for a positive MEN1 germline mutation test: evidence from Hungarian MEN1 cohort
ea0056p126
Adrenocortical cancer - the effectiveness of mitotane therapy depending on the time of therapy and the therapeutic dose
ea0056p127
Ghrelin is overexpressed in adrenal cancers and stimulates proliferation and migration of ACC cell line.
ea0056p128
The effect of temozolomide on pancreatic neuroendocrine tumours and role of MGMT and MMR system in temozolomide resistance
ea0056p129
Treatment with (177Lu)-dotatate in patients with advanced metastatic somatostatin receptor-positive tumors
ea0056p130
Severe impairments in health-related quality of life in patients with small intestine neuroendocrine tumors
ea0056p131
Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma
ea0056p132
Presence and functional role of KiSS/KiSS-R system in pancreatic neuroendocrine tumors (panNETs) and its relationship with clinical features and tumor behavior
ea0056p133
Mesenchymal tissue markers as potential drug targets in adrenocortical tumours
ea0056p134
Multiple endocrine neoplasia type 1: a retrospective monocenter analysis of 73 cases
ea0056p135
Cell line derived from glioblastoma synthesizes steroid hormone. Effect of enzyme inhibitors
ea0056p136
Unraveling the incidence and clinical patterns of neuroendocrine neoplasms in Greece, through the experience of multipotent, specialized clinical centers.
ea0056p137
Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.
ea0056p138
Prevalence of undiagnosed Medullary Thyroid Carcinoma and Phaeochromocytoma in MEN2A syndrome revealed by cascade screening
ea0056p139
Achievement of therapeutic mitotane concentrations in management of advanced adrenocortical cancer: a single centre experience in 47 patients
ea0056p140
Patients with metastatic bone disease and neuroendocrine neoplasms: the experience of a multi-center study
ea0056p141
Clinical features of 'dedifferentiation' in advanced pancreatic neuroendocrine neoplasms: the experience of two centers of excellence
ea0056p142
Clinical features of a gastric neuroendocrine neoplasms type 1 series
ea0056p143
Female Reproduction
Female fertility in congenital adrenal hyperplasia
ea0056p144
Neuroendocrinology
Non-functional duodenal neuroendocrine carcinoma- a rare cause of diabetes mellitus
ea0056p145
Preliminary study of POU1F1 (Pit1) gene expression in lactotroph and thyrotroph neuroendocrine tumours
ea0056p146
Ectopic cushing's syndrome: Six cases description
ea0056p147
Metastatic meduller thyroid cancer patient with MEN 2B who developed acute leukemia
ea0056p148
Diagnostic difficulties, management and treatment in neuroendocrine tumors
ea0056p149
Through five hospitals and 800 km, a long way from emergency department to insulinoma operation
ea0056p150
A rare association of neuroendocrine tumors
ea0056p151
Head and neck paragangliomas: genetic mutation and location of the tumors
ea0056p152
Bilateral neck paragangliomas in a patient with a family history and chronic hypoxemia
ea0056p153
The first experience of using of ultrasound with multimodal imaging technology for the diagnosis of pancreatic insulinoma
ea0056p154
Obesity
Body composition and concentration of 25-OH vitamin D as metabolic syndrome indicators in patients with non-functioning adrenal incidentalomas
ea0056p155
Paediatric endocrinology
Pediatric adrenal insufficiency: experience from a Tertiary Hospital Center
ea0056p156
Pituitary - Basic
MicroRNA profile after octreotide treatment in neuroendocrine tumor cell line
ea0056p157
Gender differences in delays to diagnosis of acromegaly: data from the Swedish National Patient Register
ea0056p158
Direct costs after diagnosis of acromegaly: Data from Swedish nationwide registries
ea0056p159
Steroid metabolism + action
Urinary steroid profile in patients with primary adrenal insufficiency under conventional glucocorticoid replacement: a case control study
ea0056p160
Steroid profile using gas chromatography tandem mass spectrometry (GC-MS/MS) in search for a steroid which correlates most with subclinical hypercortisolism
ea0056p161
Thyroid (non cancer)
Clinical aspects of the schmidt's syndrome: a 14 years retrospective monocentric study
ea0056p162
Thyroid cancer
Abstract unavailable
ea0056p163
Poster Presentations: Calcium and Bone
Bone ' Osteoporosis
Influence of the levels of vitamin D on T-score in HIP measured by DXA of colombian postmenopausal women
ea0056p164
Potential extension of frax algoritm and probability of bonefracture
ea0056p165
A case report: FGF23-related tumor-induced osteomalacia in a patient with pulmonary adenocarcinoma
ea0056p166
Abstract unavailable
ea0056p167
Features of distal forearm fracture in persons 50 years old and older
ea0056p168
Effect of surgery vs observation: 6-Year skeletal outcomes in primary hyperparathyroidism
ea0056p169
Association between Serum FGF21 levels and bone mineral density in healthy postmenopausal Korean women
ea0056p170
Bone geometry is correlated with arterial stiffness in overweight older adults with vitamin D insufficiency
ea0056p171
Effects of acromegaly on plasma microRNA levels relevant to bone metabolism.
ea0056p172
Is FGF23 a key factor in primary hyperparathyroidism?
ea0056p173
Long-term monitoring of echinococcal cyst as a cause of increased lumbar bone mineral density
ea0056p174
Acromegaly patients with vertebral fractures, have lower trabecular bone score despite no difference in bone mineral density, than non-fractured patients and healthy controls
ea0056p175
Atypical femoral fracture-a possible complication in long term use of bisphosphonates (case report)
ea0056p176
Malignant hypercalcemia induced by denosumab discontinuation in a patient with primary hyperparathyroidism
ea0056p177
An extremely high risk of recurrent fractures in an elderly patient, identified with the implementation of Fracture Liaison Service (FLS) in a trauma hospital.
ea0056p178
The comparison of parathyroid neoplasms mappings evaluated by using gray scale ultrasound images and histopathological whole slide images
ea0056p179
Evaluation of bone mineral density and vertebral fracture incidence in a group of kidney transplant recipients
ea0056p180
PTH correlates with bone turnover serum markers in patients with end stage renal disease
ea0056p181
Rapid washout in primary, secondary, and tertiary hyperparathyroidism and utility of dual radiopharmaceutical acquisition with 99 Tc-sestamibi-123I for localization of parathyroid adenomas
ea0056p182
Trabecular bone score in patients with active acromegaly
ea0056p183
Gut and bone connection: celiac disease presented as hypertrophic osteoarthropathy
ea0056p184
The main bone mass predictors in healthy young and middle-aged men: lean mass and estradiol
ea0056p185
Teriparatide treatment in a patient with atypical femoral fractures associated with long-term bisphosphonate therapy
ea0056p186
Detection of pulmonary metastases with 18F-Fluorocholine PET/CT and treatment of refractory hypercalcemia with denosumab in a patient with long term parathyroid carcinoma
ea0056p187
Bone mineral density decline following denosumab discontinuation might not be attenuated with previous bisphosphonate therapy
ea0056p188
Novel heterozygous mutation of tissue-non-specific alkaline phosphatase (TNSALP) gene causing late-onset hypophosphatasia
ea0056p189
Orthopedic patient with hearing impairment and dizziness due to the undiagnosed Paget's disease of bone
ea0056p190
Tumor-induced osteomalacia associated with mesenchymal tumor: a challenging case report
ea0056p191
Osteoprotegerin and bone metabolism markers in postmenopausal women with primary hyperparathyroidism
ea0056p192
Endocrine osteoporosis characteristics (about 177 cases)
ea0056p193
Osteoprotegerin and distal radius bone mineral density in postmenopausal women with primary hyperparathyroidism
ea0056p194
Cystic fibrosis-related bone disease in young adults affected with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure
ea0056p195
Recurrent vertebral fracture after denosumab discontinuation in a male patient with severe osteoporosis
ea0056p196
Microindentation in the study of bone properties for type 1 diabetes mellitus patients
ea0056p197
Relationships between hormonal parameters, body fat distribution and bone mineral density in women with menstrual disorders
ea0056p198
Long term follow up of patients with hypophosphatemic rickets in a Public Institution in Brazil
ea0056p199
Genetic polymorphisms may modulate bone and energy metabolism of mountain cycling ultramarathon athlete's
ea0056p200
May polymorphisms of DHFR, CBS and MTHFR genes modulate metabolic and bone remodeling parameters associated with reduced bone mineral density?
ea0056p201
Calcium & Vitamin D metabolism
Vitamin D levels in two ethnic groups of patients with diabetes
ea0056p202
Effects of steroid hormone on Calbindin-D9k expression in rat cerebellum
ea0056p203
Effects of glucocorticoid on mucin secretion by calcium-related proteins in mouse lung
ea0056p204
Effect of endocrine disrupting chemicals on the calcium channel and implantation during implantation period
ea0056p205
Clinical, paraclinical, etiological and therapeutic particularities of severe hypercalcemia: A comparative study
ea0056p206
Genetic characteristics of sensitivity of vitamin D and prevalence of vitamin deficiency among patients of polyclinics
ea0056p207
A Curious phenomenon of Post radioiodine therapy induced hypocalcemia in Graves' disease: Case series
ea0056p208
Primary hyperparathyroidism in the elderly
ea0056p209
Edentulous jaw and Primary HyperParathyroidism
ea0056p210
Coeliac Disease complicating Autoimmune Hypoparathyroidism with Recalcitrant Hypocalcaemia
ea0056p211
The prevalence of Vitamin D deficiency in a Greek and a Cypriot population sample
ea0056p212
Epidemiology of primary hyperparathyroidism in Santander, Spain
ea0056p213
Human Chorionic Gonadotrophin (hCG) as a diagnostic test to differentiate between Parathyroid Carcinoma, Primary Benign Hyperparathyroidism and Secondary Hyperparathyroidism.
ea0056p214
Reliabilty of serum Calcium to Phosphorus (Ca/P) ratio as an accurate and inexpensive toolto define disorders of Ca-P metabolism: preliminary data
ea0056p215
Secondary hyperparathyroidism after obesity surgery is associated with serum levels of 25-hydroxyvitamin D and ionized calcium
ea0056p216
The frequencies of persistent hyperparathyroidism and hypercalcemia after kidney transplantation: a single-center experience
ea0056p217
Prevalence and clinico-epidemiology of vitamin D deficiency in patients with type 2 diabetes mellitus and hypertension - a Pan-India study
ea0056p218
PTH threshold for hyperparathyroidism diagnosis in vitamin D deficiency
ea0056p219
Vitamin D status in hospitalized chronic ill patients
ea0056p220
Role of 4D-TC in Primary Hyperparathyroidism Diagnosis- case report
ea0056p221
Severe hypomagnesaemia and hypocalcaemia: an uncommon but serious complication with proton pump inhibitor therapy
ea0056p222
Hip fractures and vitamin D deficiency
ea0056p223
Clinical manifestation of Hypoparathyroidism in a monocentric cohort: our experience
ea0056p224
Primary hyperparathyroidism due to a parathyroid adenoma with cystic degeneration presenting as recurrent acute pancreatitis
ea0056p225
Glucose metabolism in primary hyperparathyroidism: The role of parathyroidectomy
ea0056p226
Acquired Fanconi syndrome and hypophosphatemic osteomalacia in two patients treated with adefovir and tenofovir
ea0056p227
The coexistence of primary hyperparathyroidism with different auto-antibodies and autoimmune diseases
ea0056p228
Timely and dose assessment of serum parathormone and calcium levels by cinacalcet in patients with primary hyperparathyroidism: an individualized approach
ea0056p229
Coexistence of a large functioning parathyroid cyst with papillary thyroid carcinoma: a case report
ea0056p230
Assessment of calcium and vitamin D medications adherence in patients with hypoparathyroidism after thyroidectomy
ea0056p231
Preoperative serumvitamin D levels in patients with breast cancer: association with histological characteristics
ea0056p232
Association of vitamin D status with pulmonary function: potential mediation by physical function and inflammation
ea0056p233
Quantification of serum 25-hydroxyvitamin D: a comparison between competitive chemiluminescence immunoassay and mass spectrometry coupled to high performances liquid chromatography
ea0056p234
Maximal foot force and plantar pressure distribution assessed by Footscan is not affected in asymptomatic primary hyperparathyroidism patients
ea0056p235
Primary hyperparathyroidism in Russian Federation: epidemiology according to the online register
ea0056p236
Intrathyroidal parathyroid carcinoma in a chronic hemodialysis patient: a case report
ea0056p237
Raloxifene has no efficacy in reducing the risk of spontaneous vertebral fractures after denosumab discontinuation
ea0056p238
Prevalence of basal ganglia calcification in patients with pseudohypoparathyroidism
ea0056p239
Thyroid oncocytes may complicate 18F-fluorocholine PET-CT localization of parathyroid adenomas in primary hyperparathyroidism
ea0056p240
Burden of illness among patients with chronic hypoparathyroidism not adequately controlled with standard therapy by self-perception
ea0056p241
Abstract unavailable
ea0056p242
PTH secretion dynamics in patients with chronic kidney disease stage 3 and stage 4 during 1 year of observation
ea0056p243
Biological and endocrine features of Infra Clinical Hypoparathyroidism in Major Beta Thalassemia at adulthood in Algeria, screening and therapeutic management
ea0056p244
Impact of vitamin D status in clinical, biochemical, radiological and pathological parameters in primary hyperparathyroidism
ea0056p245
Milk alkali syndrome & soft tissue calcification in a patient with a history of cancer
ea0056p246
Management of parathyroid adenomas
ea0056p247
Recurrent hyperparathyroidism: parathyroid carcinoma or parathyromatosis?
ea0056p248
Prenatal hypophosphatasia with severe skull bone deficits report of a case
ea0056p249
Clinical outcome in primary hyperparathyroidism: A 10-year tertiary care centre experience in Pakistan
ea0056p250
Primary hyperparathyroidism-localisation studies' sensitivity
ea0056p251
Characterization of the parathyroid hormone requests and hyperparathyroidism etiologies in a tertiary hospital
ea0056p252
Tertiary hyperparathyroidism associated with prolactinoma - case report
ea0056p253
Effect of bariatric surgery on free vitamin D3 levels
ea0056p254
Utility of contrast-enhanced ultrasound in preoperative evaluation of primary hyperparathyroidism
ea0056p255
Abstract unavailable
ea0056p256
Primary hyperparathyroidism after thyroid surgery and autotransplantion of parathyroid gland
ea0056p257
Metabolic encephalopathy following intravenous zolendronate for hypercalcaemia of malignancy: a perfect storm
ea0056p258
Primary hyperparathyroidism: a rare cause of hypertension?
ea0056p259
Atypical Parathyroid adenoma in a young individual, presented with nephrocalcinosis
ea0056p260
Cardiovascular Endocrinology and Lipid Metabolism
Is there a relationship between mean platelet volume as a cardiac marker and serum calcium levels in patients with parathyroid disease
ea0056p261
Clinical case reports - Pituitary/ Adrenal
Hypercalcemia, hypercortisolism and multiple vertebral fractures in a 49-year-old man
ea0056p262
Clinical case reports - Thyroid/Others
Severe hypercalcemia due to atypical parathyroid adenoma
ea0056p263
Functional hypoparathyroidism secondary to magnesium deficiency in long-term users of proton pump inhibitor: case report
ea0056p264
Utility of 11C-methionine PET/CT in preoperative localization of a parathyroid adenoma in a patient with primary hyperparathyroidism: a case report
ea0056p265
Ulnar osteoclastoma as first manifestation in primary hyperparathyroidism: case report
ea0056p266
Lithium-associated Hyperparathyroidism in a Filipino woman presenting as recurrent ischemic stroke: a case report
ea0056p267
Looked like a goiter, proved to be a giant parathyroid adenoma
ea0056p268
Concomitant primary hyperparathyroidism with papillary thyroid carcinoma: The role of dual-phase 99mTc-MIBI parathyroid imaging: case report
ea0056p269
Multiple brown tumors inprimary hyperparathyroidismcaused by an adenoma mimicking metastatic bone disease with false positive results on computed tomography
ea0056p270
Regression of multipl brown tumors after surgical removal of mediastinal ectopic parathyroid adenoma
ea0056p271
Multiple hormone resistance in a patient with follicular thyroid carcinoma and papillary microcarcinoma
ea0056p272
Hypercalcemia not mediated by PTH: a case report
ea0056p273
Papillary thyroid cancer and primary hyperparathyroidism - a rare coincidence: case report
ea0056p274
Endocrine Disruptors
Role of Pro-inflammatory cytokines in Primary Hyperparathyroidism: A Prospective Study
ea0056p275
Endocrine Nursing
Prevalence of kidney stones and osteoporosis in patients with primary hyperparathyroidism
ea0056p276
Endocrine tumours and neoplasia
Somatostatin receptors 1 and 5 are novel markers of parathyroid tumor aggressiveness
ea0056p277
Vitamin D and cancer of the prostate
ea0056p278
Feasibility and efficacy in ultrasound guided percutaneous microwave ablation of primary hyperparathyrodism with parathyroid nodules
ea0056p279
Female Reproduction
Association between age at onset of menopause and fracture risk: a systematic review and meta-analysis
ea0056p280
Poster Presentations: Diabetes, Obesity and Metabolism
Adrenal cortex (to include Cushing's)
Hypoglycemia in non-diabetic patients: clinical features and causes
ea0056p281
Bone & Osteoporosis
First report of Gaucher disease in Montenegro: Genotype/phenotype correlations
ea0056p282
Hip axis length in women with type 1 diabetes mellitus
ea0056p283
Vertebral fractures in patients with type 2 diabetes mellitus
ea0056p284
Vertebral fractures in women with type 1 diabetes mellitus
ea0056p285
Proximal femur structural geometry changes in women with type 2 diabetes mellitus
ea0056p286
Case report: male adult with autosomal-dominant osteopetrosis
ea0056p287
Fragility index in type 2 diabetes for identification of patients with risk of osteoporotic fracture or prevalent fracture
ea0056p288
Calcium & Vitamin D metabolism
Relationships between vitamins and lipids in the elderly
ea0056p289
Vitamin D and obesity
ea0056p290
Vitamin D deficiency and risk of metabolic syndrome
ea0056p291
Cardiovascular Endocrinology and Lipid Metabolism
Effects of atorvastatin and ezetimibe therapy on LDL Cholesterol. A systematic review and meta-analysis of randomized controlled trial
ea0056p292
Your patients say they do not tolerate statins? You can still lower their cardiovascular risk with red yeast rice supplementation
ea0056p293
Lobeglitazone, a novel thiazolidinedione, improves hepatic steatosis in diet-induced obese mice
ea0056p294
B-type natriuretic peptide: a biomarker of cardiovascular risk in type 2 diabetes.
ea0056p295
Relationship between the triglyceride glucose index and the presence and fibrosis of nonalcoholic fatty liver disease in Korean adults
ea0056p296
Adropin concentration correlates with selected anthropometric and biochemical parameters - preliminary report
ea0056p297
Silent myocardial ischemia in type 2 diabetes patients with ischemic heart disease
ea0056p298
PCSK9 inhibitors as an add on for the treatment of dislipemia in real clinical practice
ea0056p299
Treatment adherence through an Integral Care Program for patients with Metabolic Syndrome in Central Mexico
ea0056p300
Searching the best feeding habits to improve atherogenic dyslipidemia and inflammatory activity in patients with psoriatic arthritis
ea0056p301
Worse MELD score is linked to a higher rate of metabolic syndrome in HIV/HCV co-infected patients on highly active antiretroviral therapy
ea0056p302
Improved lipid profile and cardiovascular risk factors after bariatric surgery
ea0056p303
Efficacy and safety of proprotein convertase subtilisin/kexintype nine inhibitors in real life experience
ea0056p304
Plasma insulin levels in patients with the different severity of atherosclerotic lesions of coronary arteries
ea0056p305
A multi-disciplinary approach to the management of NAFLD improves both liver and metabolic health and is cost effective
ea0056p306
A case of combined dyslipidemia with two different defined genetic alterations
ea0056p307
Soluble ST2, a promising cardiovascular biomarker, is associated with parameters of glucose and bone metabolism in subjects at cardiovascular risk
ea0056p308
Comparison of inflamatory parameters, lipid profile and clinical values in patients with clinical and subclinical hypothyroidism
ea0056p309
High levels of sclerostin are related to cardiovascular mortality
ea0056p310
Lipid profile after pregnancy in women with gestational diabetes mellitus
ea0056p311
Secondary diabetes associated with principal endocrinopathies (about 161 cases)
ea0056p312
Metabolic syndrome and triglyceride-rich lipoproteins
ea0056p313
Specificity of mathematical indexes versus histopathological findings in the diagnosis of nonalcoholic fatty liver disease in mexican population
ea0056p314
What changes does pregnancy bring to the lipid parameters of diabetic patients?
ea0056p315
Identifying metabolic unhealthy obesity using the product of triglycerides and glucose
ea0056p316
Clinical case reports - Thyroid/Others
Diabetic ketoacidosis occurring in the patient whom newly started insulin glargine U300: a case report
ea0056p317
A female patient with diabetic ketoacidosis who had hyperthyroidism and acute appendicitis
ea0056p318
Factitious hypoglycemia; Case report
ea0056p319
Development of fatal lactic acidosis after inadvertent use of metformin in a non-diabetic hemodialysis patient
ea0056p320
Effect of hemoglobin J variant on HbA1c values as measured by HPLC (high-perfomance liquid chromatography)
ea0056p321
Performance-enhancing drugs and adverse endocrine effects
ea0056p322
Maturity - onset diabetes in the young and non-alcoholic fatty liver disease: a case report
ea0056p323
Dapagliflozin and Atkins Diet in a patient with type 2 Diabetes Mellitus: A combination that should be avoided
ea0056p324
A rare cause of hypoglycemia: insulin autoimmune syndrome in a Turkish patient taking Alpha lipoic acid
ea0056p325
Post bariatric surgery malabsorption and vitamin D deficiency
ea0056p326
Diabetes and bulimia - a dangerous combination
ea0056p327
Prolonged hyperglycemia in a type 1 diabetic futsal player after a single betamethasone injection for pain in the groin area
ea0056p328
Developmental endocrinology
Glucose, lipids, and insulin in cord blood of neonates and their association with birth weight
ea0056p329
Association of RS1170806 polymorphism in ADCY5 and RS7754840 polymorphism in CDKAL1 with birth weight, neonatal glucose, insulin and insulin resistance.
ea0056p330
Diabetes (to include epidemiology, pathophysiology)
Evaluation of community pharmacy-based services for type-2 diabetes in an Albanian setting: pharmacist survey
ea0056p331
Estimation of HbA1c in hospitalized patients with bronchial asthma
ea0056p332
Inpatient diabetes management service, 30-day readmissions and length of stayof patients with diabetes
ea0056p333
Evolution of the degree of glycemic control in a cohort of patients with type 2 diabetes mellitus. study to 26 weeks
ea0056p334
Study of the association of transcription factor 7 like 2 gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy in the Egyptian population
ea0056p335
Relationship between serum zinc, glycemic status and HOMA2 parameters in a regional Australian hospital population
ea0056p336
The role of polysomnography for detection of OSA in patients with type 2 diabetes in the Uzbek population
ea0056p337
Transcription Factor 7 Like2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus in a cohort of Egyptian diabetic patients, a pilot study
ea0056p338
Undiagnosed diabetes and related risk factors in postmenopausal women: the 2011-2012 Korean National Health and Nutrition Examination Survey
ea0056p339
Comparison of quality of life and symptoms of depression in diabetes combined with gastroparesis and without it
ea0056p340
Predictors of anxiety development at diabetes mellitus type 1
ea0056p341
Comparative analysis of the prevalence of type 2 diabetes according to the screening and register data in Uzbekistan
ea0056p342
Nutrition of non-fasting patients with diabetes during the month of Ramadan
ea0056p343
Evaluation of procalcitonin levels in diabetic and diabetic nephropathic patients
ea0056p344
Telmisartan increases gluconeogenesis by inducing PKCζ-Thr410 phosphorylation in hyperglycemia-treated HepG2 cells and high-fat diet-fed mouse liver
ea0056p345
Diabetes complications and comorbidities in patients newly diagnosed with diabetes in newfoundland and labrador (NL): gender differences
ea0056p346
Visfatin concentration and anthropometric/biochemical parameters in healthy individuals-preliminary study
ea0056p347
Serum soluble vascular adhesion molecules and highly sensitive C: reactive protein in elderly type 2 diabetic patients with mild cognitive impairment
ea0056p348
Evaluating quality of diabetic care in patients with severe mental illness (SMI) in an academic primary care clinic
ea0056p349
Prorenin and secreted frizzled-related protein-4 levels in women with gestational diabetes mellitus
ea0056p350
Novel inflammatory pathways in monocytes of type 2 diabetes patients are modulated by vitamin D
ea0056p351
Serum adiponectin in male type 2 diabetic patients exposed to ionizing radiation in early years
ea0056p352
Decreased spexin levels in patients with type 1 diabetes
ea0056p353
Increase in C-peptide levels after short term glycemic control in patients with type 2 diabetes mellitus: myths or facts?
ea0056p354
Incidence of glucocorticoid-induced hyperglycemia among hospitalized nondiabetic patients
ea0056p355
Diabetes after liver transplantation
ea0056p356
Distribution of Korean obese patients based on National Health Insurance Claim Data in 2016
ea0056p357
Think insulin: a prospective study of the knowledge of insulin preparations and administration in a Cohort of nurses in district general hospital
ea0056p358
Association between NK cell activity and glucose regulation in type 2 diabetes patients
ea0056p359
The effects of Korean red ginseng on diabetic complications and glucose modulation in type 2 diabetic patients
ea0056p360
Phenotypic and autoimmunity analysis of patients with type 1 diabetes mellitus onset
ea0056p361
Is it useful the O'Sullivan test ≥200 to diagnose gestational diabetes mellitus (GDM)?
ea0056p362
Study on sphingolipids in tissues of animals with the diet-induced obesity
ea0056p363
Influence of HLA pattern on the age at onset of type 1 diabetes mellitus
ea0056p364
Lipoatrophic Diabetes Mellitus: a rare special type!
ea0056p365
Does gender-affirming hormone therapy alter insulin resistance in transgender persons?
ea0056p366
Diagnosis and optimal medical management of patients with maternally inherited diabetes and deafness (MIDD)
ea0056p367
Predictors of non-alcoholic fatty liver disease in metabolic syndrome
ea0056p368
Carbohydrate metabolism indicators in athletes who stopped using anabolic androgenic steroids
ea0056p369
Carbohydrate metabolism disorders in patients with Graves treated with systemic corticosteroid regimen
ea0056p370
A difficult synchronous diagnosis; Type 2 Diabetes and insulinoma
ea0056p371
Immunoglobulin G4 related pancreatitis; can it be a rare cause of secondary diabetes?
ea0056p372
Evaluation of glycemia correction during sleeping on the somnological indicators in type 1 diabetes patients
ea0056p373
Insulin resistance and [beta]-cell function in patients with cystic fibrosis
ea0056p374
HNF-1[beta] maturity-onset diabetes of the young (MODY 5): defining diabetes etiology in a family with different diabetes phenotypes
ea0056p375
Habitual dietary intake in response to futsal-based exercise in people with type 1 diabetes
ea0056p376
TWEAK levels in patients with prediabetes and diabetes mellitus
ea0056p377
Description of clinical, biochemical and radiological variability of Hepatocyte Nuclear Factor-1[beta]eta (HNF1[beta]) Mutations
ea0056p378
Maternally inherited diabetes and deafness (MIDD): the many faces of the same disease in a Spanish family
ea0056p379
The detection of disordered eating risk in patients with type 2 diabetes mellitus
ea0056p380
Gestational diabetes and weight gain in outpatient practice
ea0056p381
Oral glucose tolerance test in reclassification of gestational diabetes after delivery - results from portuguese national registry
ea0056p382
Relationship between circulating 25-hydroxyvitamin D and glucose homeostasis in women with postmenopausal osteoporosis
ea0056p383
Demographic and clinical factors associated with having ischemic heart disease as a multiple contributing causes of death among diabetes mellitus deaths in the United States and Brazil
ea0056p384
Gestational diabetes - association of lipid profile in pregnancy with post-partum dysglycemia
ea0056p385
Changes in the glutathione system in patients with impaired carbohydrate metabolism
ea0056p386
The effect of the dopamine agonist cabergoline on insulin sensitivity in the skeletal muscle: an in vitro study in a mouse cell model demonstrating mediation by serotoninergic receptors
ea0056p387
Eating habits, food choices and physical activity in adult patients with type 1 diabetes mellitus
ea0056p388
Preconception management in type 2 diabetes mellitus (T2DM): there is still much work to do
ea0056p389
Kinky and sparse hair as an associated finding inmaternally inherited diabetes and deafness
ea0056p390
Stiff - person syndrome in an old woman with late onset type 1 diabetes mellitus
ea0056p391
Autoimmune hypoglycemia in a patient with slow type 1 diabetes
ea0056p392
Insulin resistance in diabetes mellitus type 1, and its association with cardiovascular disease, sex hormones
ea0056p393
Mitochondrial diabetes in 40 patients belonging to 30 Tunisian families: phenotypic and genotypic heterogeneity
ea0056p394
Hyperandrogenaemia in women with type 1 diabetes mellitus; associations with lipids and lipoprotein particle size, and early vascular disease
ea0056p395
Association of the FTO gene rs9939609 polymorphism with carbohydrate metabolism disorders in the Republic of Tatarstan
ea0056p396
Reactive hypoglycaemia - a debilitating condition
ea0056p397
Abstract unavailable
ea0056p398
Metabolic syndrome in patients with latent autoimmune diabetes of adults (LADA)
ea0056p399
Gestational diabetes and postpartum follow up
ea0056p400
Glycemic variability and diabetes-related antibodies titer at diagnose in type 1 diabetic patients: is there a correlation?
ea0056p401
Major adverse cardiovascular events and in-hospital outcomes in patients with diabetes
ea0056p402
Screening for autoimmune endocrinopathiesAt 300 insulin-dependent diabetics type1
ea0056p403
Diabetes complications
Mortality related to diabetes in orthopedic surgery patients
ea0056p404
Mortality related to diabetes in vascular surgery patients
ea0056p405
Diabetes and other frequent clinical problems in patients admitted in orthopaedic surgery
ea0056p406
Abstract unavailable
ea0056p407
Oral health care behaviors among Tunisian patients with diabetes mellitus.
ea0056p408
Clinical evaluation of erectile dysfunction in diabetic patients by IIEF5 Score
ea0056p409
Variability of glycemia and cognitive function in patients with type 1 diabetes mellitus
ea0056p410
Septicemia in diabetics in Tunisia: Study of 43 cases
ea0056p411
An association of non-alcoholic fatty liver disease and autonomic neuropathy parameters in patients with type 2 diabetes
ea0056p412
Characteristics of cardiovascular autonomic neuropathy depending on the type of diabetes and importanace of cardiovascular tests in diagnostics
ea0056p413
Importance of HBA1C level and BMI in patients with chronic kidney disease
ea0056p414
The results of questionnaire by comprehensive symptom profile diabetes mellitus hypoglycemia nodule in type 2 diabetes patients
ea0056p415
Comparitive angiographic profile in diabetic and non-diabetic patient (retrospective study)
ea0056p416
Thiol-disulfide homeostasis, total antioxidant capacity and advanced oxidant protein products in patients with diabetic peripheral neuropathy
ea0056p417
Association of dislipidemia and glycemic control in patients with type 1 diabetes mellitus
ea0056p418
Urinary neutrophil gelatinase-associated lipocalin (NGAL) as a marker of diabetic nephropathy in type 1 diabetic patients
ea0056p419
APOB/APOA1 ratio is associated with metabolic syndrome in type 2 diabetes mellitus women with ischemic cardiomiopathy
ea0056p420
Soluble dipeptidyl peptidase-4 activity is associated with decreased renal function in patients with type 2 diabetes
ea0056p421
Predictors of the development of androgen deficiency in men with type 1 diabetes mellitus
ea0056p422
Relationship between serum levels of HDL cholesterol subclasses and carotid intima media thickness in patients with type 1 diabetes mellitus
ea0056p423
Dyslipidemia: type 1 diabetes vs. type 2 diabetes
ea0056p424
The comparison of serum cerebellin and catecholamine levelsin patients with newly diagnosed hypertension and type 2 diabetic whose had newly diagnosed hypertension
ea0056p425
The prevalence of microvascular complications in the adults with type 1 diabetes and the glycemic control in the Republic of Belarus
ea0056p426
Inflammation in patients with diabetic nephropathy receiving different classes of glucose-lowering medications: serum levels of interferon gamma
ea0056p427
The relationship between morbidity and mortality and HbA1c level in major surgery applied with diabetic patients
ea0056p428
The relationship between intertemporal choice and blood glucose control in type 2 diabetes
ea0056p429
Characteristics of diabetic foot patients admitted to department of endocrinology and metabolic diseases at ankara university, faculty of medicine
ea0056p430
Atherosclerosis in women of reproductive age with type 2 diabetes mellitus and polycystic ovary syndrome
ea0056p431
Association of adverse pregnancy outcomes with glycemic cut-offs stated by the IADPSG, POGS and WHO diagnostic criteria for gestational diabetes mellitus in De La Salle University Medical Center (DLSUMC), Cavite, Philippines from January 2012 to December 2015
ea0056p432
Ankle-brachial index values in diabetic patients with and without claudication
ea0056p433
Analysis of kidney biopsy findings in diabetic patients
ea0056p434
Hypomagnesemia as a marker of diabetic nephropathy
ea0056p435
Association cystatin C with the presence of carotid atherosclerosis in patients with diabetes type 2 and chronic kidney diseaseassociation cystatin C with the presence of carotid atherosclerosis in patients with diabetes type 2 and chronic kidney disease
ea0056p436
Diabetic ketoacidosis among SGLT2i-treated patients: insight from a single medical center located in the region with the highest diabetes mellitus mortality rate in Israel
ea0056p437
Investigation of serum SCUBE-1 level in relation to microvascular complications in patients with type 2 diabetes mellitus
ea0056p438
Hyperlipidemia during gestational diabetes: maternal and offspring complications
ea0056p439
Osteopontin levels in plasma, muscles and bone in patient with non-healing diabetic foot ulcers: a new player in wound healing process?
ea0056p440
Impaired awareness of hypoglycaemia does not affect the prevalence of diabetes-related distress in people with diabetes type 1
ea0056p441
The comparison of the fate of arteriovenous fistula in diabetic and non-diabetic recipients following kidneytransplantation
ea0056p442
TSH and adiponectin levels in patients with diabetic kidney disease after renal transplantation
ea0056p443
Knowledge and Attitudes of Trainee Doctors in the Management of DKA and Compliance with current Protocol in a large University Teaching Hospital
ea0056p444
The association between glycemic markers and variability with plasma adipocytokine levels and markers of endothelium dysfunction in women with pregestational diabetes mellitus
ea0056p445
Acoustic Radiation Force Impulse Elastography and Ultrasonographic Findings of Achilles Tendon in Patients with and without diabetic peripheral neuropathy: a cross-sectional study
ea0056p446
Impact of systemic and local cytokine status in diabetic foot syndrome on ulcers healing rate
ea0056p447
The relationship between cardiovascular autonomic neuropathy and the severity of coronary atherosclerosis
ea0056p448
Type 1 diabetes is associated with a differential pattern of carotid atherosclerotic plaque types
ea0056p449
Neurosensorial hearing loss in type 2 diabetic patients
ea0056p450
Serum level of the autophagy biomarker beclin-1 in patients with diabetic nephropathy
ea0056p451
The comparison of longevity of arteriovenous fistula in hemodialysis patients with or without diabetes mellitus
ea0056p452
Endothelial dysfunction in the diabetic foot
ea0056p453
Polyglandular Autoimmune Syndrome Type III(PAS) onset with diabetic ketosis caused by the insulin analog induced anti-insulin antibody: successful treatment with human insulin
ea0056p454
Bone markers and bone integrity in type 2 diabetes
ea0056p455
Levels of scerostostin in serum and femoral vascular tissue and its relationship with atherosclerosis and cardiovascular mortality in patients with and without type 2 diabetes
ea0056p456
Serum lipid changes during pregnancy and after delivery in women with previous gestational diabetes
ea0056p457
The relationship between oxidative stress markers and carotis intima media thickness in patients with diabetic microvascular complications
ea0056p458
Predictors of perinatal complications in pregnant women with gestacional diabetes
ea0056p459
Role of the lipid profile as a predictive factor in the development of diabetic retinopathy in patients with type 1 diabetes
ea0056p460
Markers of nitrosative stress, angiogenesis and inflammation linked to severity of complications in type 1 diabetes
ea0056p461
Nonalcoholic fatty liver disease in men with type 2 diabetes mellitus and androgen deficiency
ea0056p462
Influence of ethnicity on gestational diabetes mellitus in the center of Israel: a retrospective cohort study
ea0056p463
Subclinical atheromatous disease detection improves cardiovascular event prediction in chronic kidney disease with and without diabetes
ea0056p464
Wrist and ankle measurements in patients with and without diabetes-related macrovascular disease
ea0056p465
Prevalence and risk factors of diabetes in chronic viral hepatitis B and C: about a retrospective study
ea0056p466
Hypoglycemia in patients with type 2 diabetes mellitus in geriatric population
ea0056p467
Predictors for low bone mineral density assessed with DXA and trabecular bone score in patients with diabetes mellitus
ea0056p468
Is-it safe for diabetic patients to fast during Ramadan?
ea0056p469
Risk factors for delay gastric emptying in patients with type 2 diabites
ea0056p470
Clinical and laboratory predictors of positive renal effects of vildagliptin
ea0056p471
An assessment of abnormal liver function tests in a cohort of unselected diabetic patients
ea0056p472
The effect of glutathione S-transferase M1 and T1 polymorphisms on ascorbic acid plasma levels in diabetic patients
ea0056p473
Maternofetal complications of diabetic pregnancy: about 293 cases
ea0056p474
Bacterial lower limb dermo-hypodermitisin diabetic patients: what epidemiological, clinical and therapeutic particularities? About 134 cases
ea0056p475
Diabetes therapy
Analysis of safety and efficacy of liraglutide compared with dulaglutide in patients with type 2 diabetes mellitus
ea0056p476
A localized painfull rash induced by linagliptin in a patient with type 2 diabetes
ea0056p477
Preservation of residual [beta]-insulin function in a patient with a type 1 diabetes treated early by fingolimod for multiple sclerosis
ea0056p478
Treating depression in insulin dependant diabetics improves glucoregulation
ea0056p479
Comparative analisis of multiple daily injection of insulin and continuous subcutaneous insulin infusion regimes in children and adolescents with type 1 DM in Uzbekistan
ea0056p480
Perinatal outcomes in Mexican women with mild gestational diabetes mellitus without treatment diagnosed by the international association of diabetes and pregnancy study groups criteria
ea0056p481
Meta-analysis of clinical efficacy of traditional chinese medicine formula (Simiao Yong'an Decoction) in treatment of diabetic foot meta-analysis of clinical efficacy of traditional chinese medicine formula (Simiao Yong'an Decoction) in treatment of diabetic foot
ea0056p482
Maculopapular rash developed after initiation of U-300 glargine insulin in a patient with type 1 diabetes mellitus
ea0056p483
Dapagliflozin after liraglutide in patients with type 2 diabetes
ea0056p484
Canagliflozin after liraglutide in patients with type 2 diabetes
ea0056p485
Inhibitors SGLT2 after liraglutide in patients with type 2 diabetes
ea0056p486
Second setp in type 2 diabetes, what to choose?
ea0056p487
Short term adherence with discharge recommendation for insulin treatment among patients with type 2 diabetes
ea0056p488
Dulaglutide; effectiveness in a real world population with type 2 diabetes
ea0056p489
Experience in clinical practice with new long-acting insulins in type 2 diabetes (T2D)
ea0056p490
Six months of retrospective glycemic control and anthropometric outcomes in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data from single center
ea0056p491
Can patient profile influence on GLP1 analogues prescription among physicians?: patient selection and perspectives
ea0056p492
SGLT-2 inhibitors or GLP-1 receptor agonists as add-on to insulin therapy in patients with type 2 diabetes: comparative analysis
ea0056p493
Clinical predictors of therapeutic response to SGLT-2 inhibitors
ea0056p494
Improvement control rate of blood glucose/blood pressure/blood lipid in diabetes patients by hospital-community integrated management in Shanghai
ea0056p495
Abstract unavailable
ea0056p496
A case with metformin overdose associated acidosis
ea0056p497
Cognitive status, anxiety and depression in patients with type 2 diabetes mellitus on selective DPP4 inhibitor therapy
ea0056p498
Metabolic effects of liraglutide in type 2 diabetic patients.
ea0056p499
Efficacy of glucose control on a combination of dapagliflozin in people with type 2 diabetes mellitus in Korea
ea0056p500
Comparison of occurrence of fasting hyperinsulinemia according to type of insulin analogs
ea0056p501
The impact of different glucose-lowering regimens on cardiovascular disease in type 2 diabetes
ea0056p502
Evaluation of the risk of hypoglycemias using a questionnaire in patients with type 2 diabetes
ea0056p503
The intensity of metabolic processes due to different variants of polymorphism rs1801282 Pro12Ala of the PPARG gene in patients with diabetes mellitus type 2
ea0056p504
A latent autoimmune diabetes in adults (LADA) case renamed after six years of diabetes diagnosis when complicated with diabetic ketoacidosis induced by dapagliflozin
ea0056p505
Awareness of patients with diabetes on the disease
ea0056p506
Efficacy in metabolic control and weight loss of combined treatment with GLP-1 receptor analogues and SGLT-2 inhibitors
ea0056p507
Insulin requirements and obstetric outcomes in pregnant woment with type 1 diabetes under continuous subcutaneous insulin infusion (CSII)
ea0056p508
Addition of sodium-glucose co-transporter type 2 inhibitors to diabetic patients type 2 in treatment with glucagon-like peptide-1 agonists: clinical results
ea0056p509
Psychopathological determinants of enhanced quality of life in continuous subcutaneous insulin infusion therapy
ea0056p510
Effects of opuntia ficus-indica plant extract ingestion on glucose and insulin plasma levels during oral glucose tolerance test
ea0056p511
Predictive factors of starting insulin in gestational diabetes' Management: About 191 cases
ea0056p512
Safety and efficacy of different insulin regimens in treatment of type 2 diabetic patients who insist to fast during Ramadan 1437 (Hijri) In Fayoum Governorate, Egypt
ea0056p513
Pregnancy and diabetes: an overview about 144 patients
ea0056p514
Moroccan woman pregnant diabetic: what dietary errors? About 60 cases
ea0056p515
The flexible insulin therapy: satisfaction after the change of treatment? About 73 cases
ea0056p516
Long-term results of continuous subcutaneous insulin infusion on glycemic control and severe hypoglycemias
ea0056p517
The anxiety and depression disorders in the diabetic type 1 (preliminary results)
ea0056p518
Endocrine Disruptors
Intermittent fasting for three months decreases pancreatic islet mass and increases insulin resistance in Wistar rats
ea0056p519
Cognitive impairment and nutritional status in patients admitted to the Department of Internal Medicine
ea0056p520
Deleterious effect of low-dose persistent organic pollutants on insulin secretion in pancreatic [beta]-cell
ea0056p521
GLP-1 increases the availability of substrates and prioritizes the use of lipids in muscle metabolism
ea0056p522
Plasma levels of perfluoroalkyl substances and risk of type II diabetes mellitus: a prospective nested case-control study
ea0056p523
Endocrine Nursing
Evaluation of the technique of insulin injection Analogue in Tunisia in diabetic type 2 and impact on the glycemic balance: study 56 cases
ea0056p524
Female Reproduction
Non-alcoholic fatty liver disease and polycystic ovarian syndrome in lean and obese women of reproductive age
ea0056p525
Neuroendocrinology
Analysis of the results of fasting test in hypoglycemias study
ea0056p526
Nuclear receptors and Signal transduction
Calbindin-d9k interacts with Mucin1, which influences the stability of Hypoxia inducible factor-1a
ea0056p527
Genotype- Phenotype correlations of TNF-[alpha], IL-6 and Leptin receptor gene polymorphisms in Poly cystic ovarian syndrome
ea0056p528
Association of habitual physical activity with leptin gene expression in visceral and subcutaneous adipose tissues among non-diabetic people
ea0056p529
Obesity
Anti-insulin resistant effect of ferulic acid in high-fat diet-induced obese mice
ea0056p530
Non-alcoholic fatty liver disease and its association with insulin resistance in an obese population
ea0056p531
Using on-line program of good nutrition and wright diet may reduce the risks of diabetes mellitus in the future
ea0056p532
Effectiveness of bariatric surgery in metabolically healthy obese patients
ea0056p533
The relationship between obesity, insulin resistance and conjunctival impression cytology
ea0056p534
Effect of the Andean plant Lampaya on NF-κB and JNK phosphorylation in human macrophages treated with palmitic acid.
ea0056p535
The effect of n-3 PUFA on lipid profile, inflammation and insulin resistance
ea0056p536
Differences in adipocyte size and adipogenic potential in metabolically healthy and unhealthy obese bariatric surgery patients
ea0056p537
Glucocorticoid positively regulate Agouti-related protein gene
ea0056p538
Relationship between body image perception, diet trial and depression in Korean adults: Korea National Health and Nutrition Examination Survey 2014
ea0056p539
Obstructive sleep apnea syndrome frequency in obese patients
ea0056p540
Impact of bariatric surgery on working productivity in patients with morbid obesity
ea0056p541
Associations of circulating adipokine levels with metabolic risk factors and renal function in a general population
ea0056p542
Association of sleep duration and obesity according to sex and age in Korean adults: results from the Korea national health and nutrition examination survey 2007-2015
ea0056p543
Relation of serum irisin levels, non-alcoholic fatty liver disease, glucose and lipid metabolism parameters in obese children
ea0056p544
Do dietary acidic and basic amino acids intake play role in FTO gene expression among non-diabetic adults?
ea0056p545
Long term dietary intake of aromatic amino acids are associated with leptin gene expression in adipose tissues of non-diabetic adults
ea0056p546
Assessment of macrophage apoptosis inhibitor (AIM), monocyte chemotactic protein-1 (MCP-1) and C reactive protein (CRP) levels in patients with metabolic syndrome
ea0056p547
Oxidized low-density lipoprotein (oxLDL) as a possible biomarker of cardiovascular diseases in obese subjects
ea0056p548
Effects on comorbidities and safety of bariatric surgery in morbid obesity patients
ea0056p549
Association of total antioxidant capacity and p53 mRNA levels in subcutaneous adipose tissue of obese subjects
ea0056p550
Influence of lifestyle modification on leptin and insulin resistance to prevent type 2 diabetes mellitus development
ea0056p551
Postprandial glucose, insulin, and incretin responses to different type of breads in healthy overweight and obese individuals
ea0056p552
The effects of bariatic surgery on clinical, renal parameters and urine ngal levels in diabetic and non-diabetic obese patients
ea0056p553
Abstract unavailable
ea0056p554
Are there differences in cardiovascular risk between metabolically healthy and sick obese?
ea0056p555
Menopausal hormone therapy is associated with reduced fat mass and in particular a significant decrease of the intravisceral abdominal fat, the OsteoLaus cohort
ea0056p556
Effect of surgical weight loss on the inflammatory hematological parameters in short term
ea0056p557
Carotidintima-mediacomplexthickness and sex steroid levels in severly obese women of reproductive age
ea0056p558
Effect of pre-gestational weight and gestational weight gain in women with gestational diabetes controlled with medication on pregnancy outcome-is recommended weight gain too liberal?
ea0056p559
The effects of endurance exercise training on chemerin, apelin, and visfatin in metabolically healthy obese young males
ea0056p560
Absence of leptin signaling during development causes metabolic and neuronal disturbances in adult life
ea0056p561
The relationship between arterial stiffness and obesity in kidney transplant recipients
ea0056p562
Anti-obesity effect of green alga sulphated polysaccharide on high fat diet
ea0056p563
Serum oxytocin in elderly patients with metabolic syndrome
ea0056p564
Study on some biochemical parameters in peripheral blood of animals upon diet-induced obesity and insulin resistance modeling
ea0056p565
Does follicle stimulating hormone effect adiposity in patients with hypergonadotrophic hypogonadism: a retrospective study
ea0056p566
Psychosocial aspects and hygiene-dietetic habits in a group of patients in follow-up before bariatric surgery
ea0056p567
Psychosocial aspects and hygiene-dietetic habits in a group of patients intervened for bariatric surgery
ea0056p568
Body mass index versus visceral adiposity index as predictors for dyslipidemia and liver stiffness in HIV/HCV co-infected patients with liver fibrosis
ea0056p569
Abstract unavailable
ea0056p570
Effect of 8 weeks of hypocaloric diet and physical activity on thyroid hormones, irisin and insulin sensitivity in obese otherwise healthy subjects.
ea0056p571
The comparison of different obesity criterias in kidney transplant recipients
ea0056p572
Effect of the rs12324955 polymorphism of the FTO gene in the intervention for the weight reduction in obese patients with the use of technological resources
ea0056p573
Novel indicator of abdominal obesity strongly associated with cardiovascular disease
ea0056p574
The effect of laparoscopic sleeve gastrectomy on kidney function
ea0056p575
Prevalence and pathophysiology of early dumping in patients after primary Roux-en-Y gastric bypass during a mixed meal tolerance test
ea0056p576
Weight loss and metabolic parameters after laparoscopic sleeve gastrectomy
ea0056p577
Anthropometric and body composition evolution in individuals in weight loss
ea0056p578
Free and dipeptide forms of L-glutamine supplementation attenuate parameters of oxidative stress and nonalcoholic fatty liver disease (NAFLD), and improve glucose metabolism in insulin resistant Ob/Ob mice
ea0056p579
Role of IGF1 in regulation of SOD 1 expression and mTOR/S6K signaling in heart of obese male rats
ea0056p580
Plasma metabolomic markers of insulin resistance in humans.
ea0056p581
[ldquo]A new life in a new body[rdquo]: the evolution of pregnancy following bariatric surgery in obese females
ea0056p582
Temporal analysis of the HFD consumption in the mice small intestine physiology: possible correlation between metabolic disorders and HFD-induced obesity
ea0056p583
Effect of gastrointestinal hormones on bone metabolism after bariatric surgery
ea0056p584
Relationship between human adipose tissue autophagy, obesity and glycemic status
ea0056p585
A newly inflammatory marker in overweight patients: triggering receptor expressed on myeloid cellls-1
ea0056p586
Pre-operative evaluation of obese patients admitted for bariatric surgery: observations suggesting the introduction of a detailed screening for thyroid diseases
ea0056p587
Strength training results in reduced fat accumulation and improved blood lipid profile even in the absence of skeletal muscle hypertrophy in obese rats induced by high-fat diet
ea0056p588
Association between Leptin gene polymorphisms and plasma leptin level in three consanguineous families with obesity
ea0056p589
Quality of life after sleeve gastrectomy
ea0056p590
Folic acid status in morbidly obese patients seeking sleeve gastrectomy
ea0056p591
Activation of p53 with low doses doxorubicin reduce the acumulation of lipids in two in vitro models of liver steatosis
ea0056p592
Association of dietary factors and dynamic thiol/disulphide homeostasis in subjects with coronary artery disease
ea0056p593
Effects of a combined lifestyle intervention on anthropometric parameters and long-term cortisol after 10 and 75 weeks: a longitudinal study
ea0056p594
The preoperative diagnosis of type 2 diabetes in the absence of antidiabetic treatment is associated with a worse performance after gastric-bypass compared to patients without diabetes
ea0056p595
Investigation of the effect of dietary fat content on obesity and metabolic syndrome in smokers
ea0056p596
Food addiction: its prevalence among obese patients
ea0056p597
Abstract unavailable
ea0056p598
Deciphering the functional role of host-microbiota interactions on metabolic health induced by Roux-en-Y gastric bypass (RYGB) surgery
ea0056p599
Obesity and dementia: the misleading [ldquo]obesity paradox[rdquo]
ea0056p600
Influence of body weight loss on gait and stability function in patients with obesity
ea0056p601
Magnetic resonance imaging of human supraclavicular brown adipose tissue
ea0056p602
Benign symmetric lipomatosis (Madelung's disease)
ea0056p603
DXA Body Composition with Visceral Fat analysis improves categorization of the metabolic diseases risk
ea0056p604
Influence of sleeve gastrectomy on leptin to adiponectin ratio in severely obese adults: A prospective cohort study
ea0056p605
Differences in percentage of weight loss and secondary effects after one and two months of treatment with liraglutide versus naltrexone/bupropion
ea0056p606
Prevalence of obesity in a population of patients with HIV: relationship with clinical lipodistrophy, effect of sex, age, viral replication, duration of disease and cart
ea0056p607
Paediatric endocrinology
rs1800497 polymorphism of the DRD2 Gene assosiation with plasma leptin and dofamine Levels in obese and lean children
ea0056p608
The correlation between urinary ketosis and metabolic indices in healthy young adolescents of Korea
ea0056p609
Peculiarities of functional activity of thrombocytes in adolescents with diabetes mellitus tipe 1
ea0056p610
Steroid metabolism + action
Sex differences in glucocorticoid-induced metabolic disturbances in mice
ea0056p611
Thyroid cancer
A case of diabetic patient with recurrent ketosis after U-300 glargine treatment
ea0056p612
Poster Presentations: Environment, Society and Governance
Diabetes therapy
Safety and efficacy of the available oral anti diabetic drugs in treating type-2 diabetics during Ramadan1437(Hijri)fasting in Fayoum Governate
ea0056p613
Endocrine Disruptors
Assessment of endocrine disrupting chemical screening using differentiated cardiomyocyte from mES cell
ea0056p614
Disruption of amelogenesis by Adult Exposure to Di(2-ethylhexyl) Phthalate in Mice
ea0056p615
Neuroendocrinology
Use of a new classification algorithm based on administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy
ea0056p616
Pituitary - Clinical
Living with acromegaly: patient journey in europe vs USA
ea0056p617
Thyroid (non-cancer)
Online health information seeking behavior by patients prior to their outpatient appointments in endocrinology
ea0056p618
Overuseoflaboratory and ultrasonographic examinations in thyreidology: Study from the Slovak Republic
ea0056p619
Restless legs syndrome in population of patients with thyroid disease in comparison to general populaton - questionnaire study
ea0056p620
Poster Presentations: Interdisciplinary Endocrinology
Adrenal cortex (to include Cushing's)
Corticosteroid secretion after the soy extract application to orchidectomized adult male rats
ea0056p621
High prevalence of suppressed adrenal cortical function in kidney transplanted patients during low-dose prednisolone therapy
ea0056p622
Calcium ' Vitamin D metabolism
Frequency of multiple endocrine neoplasia-1 in patients with primary hyperparathyroidism
ea0056p623
Cardiovascular Endocrinology and Lipid Metabolism
Impact of the metabolic syndrome on the renal function after partial nephrectomy for nonmetastatic localized renal cell carcinoma
ea0056p624
Is SFRP-4 an early potential biomarker related to diabetes and hypertension, in patients with androgenic alopecia?
ea0056p625
Multi-hormonal deficits in heart failure with preserved ejection Fraction: prevalence and impact on diastolic dysfunction
ea0056p626
Cross-hormone treatment: review of cardiovascular risk factors and bone mineral density in 25 transsexual subjects followed in a tertiary hospital
ea0056p627
How the diagnose of the dilatation of ascending aorta in Turner syndrome can be verified?
ea0056p628
Fibroblast growth factor-21 predicts adverse outcome in community-acquired pneumonia
ea0056p629
Clinical case reports - Pituitary/Adrenal
Low dose duloxetine and the risk of hyponatraemia
ea0056p630
Endocrine disorders in a patient affected by MELAS syndrome: a case study
ea0056p631
Clinical case reports - Thyroid/Others
Patient with neurofibromatosis type 1 and follicular thyroid cancer
ea0056p632
A rare mediastinal signet-ring cell carcinoma revealed after postpartum thyroiditis - a coincidence or a link?
ea0056p633
When it is the time of prophylactic thyroidectomy to children with medullary thyroid cancer with RET proto-oncogene Cys634Trp mutation in a family with multiple endocrine neoplasia type 2A
ea0056p634
Subacute thyroiditis in association with psoriasis and behcet's disease
ea0056p635
Primary haemoglobinopathies as a cause of secondary endocrinopathies
ea0056p636
Developmental endocrinology
Effect of desacyl ghrelin on protein expression of GHS-R1 receptor in human placental cells
ea0056p637
Diabetes (to include epidemiology, pathophysiology)
Short-term impact of the 2017 diabetes awareness day in Greece
ea0056p638
Optimization of the use of outpatient diabetes center through a coordinated task force between primary care and endocrinology unit
ea0056p639
The 4-hydroxynonenal mediated oxidative damage of blood proteins and lipids involves secondary lipid peroxidation reactions
ea0056p640
Effect of duration of exposure to glucose-based peritoneal dialysis fluid on peritoneal membrane thickness
ea0056p641
Coexistence of mitochondrial diabetes and primary amyloidosis
ea0056p642
Endocrine Disruptors
Role of Pro-inflammatory biomarkers in Graves' disease: A case-control Study
ea0056p643
Endoplasmic reticulum stress-mediated apoptosis and cell cycle arrest were caused by resveratrol, a phytoestrogen, in malignant melanoma cells
ea0056p644
Endocrine related adverse events associated with immune checkpoint blockade therapy: a retrospective analysis
ea0056p645
Endocrine tumours and neoplasia
Evolution of endocrine surgery during three consecutive years in a tertiary-care university hospital of Madrid (Spain)
ea0056p646
New germline mutation of the CDC73 gene in a Romanian family with hyperparathyroidism-jaw tumour syndrome
ea0056p647
Quality of life after medical versus surgical castration for locally advanced or metastatic prostate cancer
ea0056p648
Endocrinological side effects of immunotherapy
ea0056p649
Non-genomic effects of thyroid hormones on mesenchymal stem cells in tumour angiogenesis
ea0056p650
Targeting Treatment Resistance in Breast Cancer Subtypes via LMTK3 Inhibition
ea0056p651
Metformin and Simvastatin: a therapeutic combination to reduce the aggressiveness of glioblastoma multiforme
ea0056p652
Inhibition of alternative splicing using the spliceosome inhibitor Pladienolide B reduces aggressiveness of prostate cancer cells in vitro
ea0056p653
Fibroblast-kinome silencing to identifies putative mediator of Triple-negative breast cancer (TNBC) invasion
ea0056p654
Expression of Toll/interleukin-1 receptor (TIR)-associated protein in primary hyperparathyroidism.
ea0056p655
Expression of TICAM-2 in hyperplastic lesions of the parathyroid glands.
ea0056p656
Female Reproduction
Dream recall and content vs the menstrual cycle: a cross-sectional study
ea0056p657
Autoimmune thyroiditis and repeated pregnancy loss: a role for associated autoimmune disorders?
ea0056p658
Audit of the management of adult patients with turner syndrome at the Nottingham University Hospitals (NUH), England
ea0056p659
Cognitive functions in adult women with turner syndrome
ea0056p660
Screening for liver abnormalities in turner syndrome: audit from a single centre
ea0056p661
Cardiac evaluation in turner syndrome: echocardiography versus cardiac magnetic resonance
ea0056p662
Growth hormone IGF axis - basic
IGF-1 corellates with cognitive status in esrd patients undergoing haemodialysis
ea0056p663
IGF-I is not suppressed in adolescents submitted to resistance training and can be a marker of training status
ea0056p664
Effects of zinc, magnesium and vitamin B6 (ZMA) supplementation on serum IGF-I, IGFBP-3 and Testosterone concentrations in young athletes
ea0056p665
Neuroendocrinology
Single center three years' experience with non-diabetic hypoglycemia in a tertiary hospital, Nepal
ea0056p666
Does gender affirming hormone therapy affect anger proneness in transgender persons?
ea0056p667
Cigarette smoking and neuroreceptors genetic variations: a handshake between genetic and environmental factors leading to nicotine addiction
ea0056p668
Association of OPRD1 rs569356 SNP with Stress Response in opioid addicts
ea0056p669
Pro-inflammatory Socs3 inactivation in Kiss1-expressing cells does not affect reproduction and metabolism in mice
ea0056p670
Abstract unavailable
ea0056p671
Abstract unavailable
ea0056p672
Nuclear receptors and Signal transduction
Vitamin D abolishes the dexamethasone-induced apoptosis in acute myeloid leukemia cells via regulation of Notch signaling
ea0056p673
1,25 dihydroxyvitamin D reverses everolimus resistance in hepatocellular carcinoma activating mesenchymal-epithelial transition and miR-375
ea0056p674
Inactive AT1 angiotensin receptor acts as a signaling hub: a novel mechanism of receptor cross-talk
ea0056p675
Obesity
Gender specific differences in patients with metabolic syndrome and major depression
ea0056p676
Paediatric endocrinology
Awareness & participation in rare disease registries within the European reference network on rare endocrine conditions (Endo-ERN)
ea0056p677
Long-term endocrine sequelae of patients with beta-thalassemia following bone marrow transplantation in childhood/adolescence
ea0056p678
Non-classical congenital adrenal hyperplasia: the most frequent mutations
ea0056p679
Steroid metabolism + action
Characterization of sex hormone binding globulin ligands with potential to enhance sex steroid action
ea0056p680
Relationship between salivary cortisol circadian rhythm and body composition in the postmenopausal women of the population cohort OsteoLaus
ea0056p681
Proteolytically cleaved forms of corticosteroid-binding globulin with low steroid-binding affinity are not present in human plasma
ea0056p682
Thyroid (non-cancer)
Role of Pro-inflammatory biomarkers in Hashimoto's thyroiditis: A prospective study
ea0056p683
Autoimmune thyroiditis and chronic spontaneous urticaria - case series
ea0056p684
Thyroid cancer
Late diagnosis of type 2B multiple endocrine neoplasia (MEN 2B) in a 24-year-old patient
ea0056p685
Poster Presentations: Pituitary and Neuroendocrinology
Adrenal cortex (to include Cushing's)
Cyclical cushing presented as PCOS in 37 years old lady
ea0056p686
Combined cavernous and inferior petrosal sinus sampling in the differential diagnostic of ACTH-dependent Cushing's syndrome
ea0056p687
Hair cortisol in adults with Prader-Willi syndrome
ea0056p688
Absent adrenarche in adults with congenital hypopituitarism
ea0056p689
Clinical case reports - Pituitary/Adrenal
Abstract unavailable
ea0056p690
Prolonged QT intervals in a patient with empty sella and isolated ACTH deficiency.
ea0056p691
Delayed puberty vs hipogonadotropic hypogonadism; how long to wait to treat?
ea0056p692
Isolated secondary adrenal insufficiency associated with primary hypothyroidism presenting with hypoglycemic coma
ea0056p693
Clinical case of exogenous Cushing Syndrome during injections and on topical glucocorticoids
ea0056p694
An acromegaly case; presented from pituitary apoplexia to overt acromegaly before diagnosis
ea0056p695
Acute hyponatraemia complicating therapy of acute hepatic porphyria need immediate correction before become symptomatic: a case report
ea0056p696
Pasireotide a new option for acromegaly
ea0056p697
Diabetes insipidus as first clinical manifestation of pineal tumor
ea0056p698
Acromegaly and subclinical Cushing's disease: a rare case of a pituitary macroadenoma secreting both GH and ACTH
ea0056p699
Hypogonadism following high-voltage electrical brain injury
ea0056p700
A case of hypothalamic-pituitary disease: who's the deceiving suspect?
ea0056p701
Cyclic Cushing's syndrome: a difficult diagnosis
ea0056p702
A rare cause of central hypothyroidism: oral isotretinoin treatment
ea0056p703
The complexity of management of persistent acromegaly from repeated surgical interventions and multiple medical therapies
ea0056p704
A case of hypopituitarism due to acute invasive fungal rhinosinusitis
ea0056p705
An unexpected cause of severe hypokalemia
ea0056p706
Atypical pituitary adenoma: a case of histological mimicry
ea0056p707
Bromocriptine for management of a patient with cranipharyngioma and central hyperthermia after neurosurgery: a case report
ea0056p708
Successful management of Cushing's disease in pregnancy: a case report
ea0056p709
A case of diabetes insiputus due to ectopically located neurohypophysis presented during pregnancy
ea0056p710
A case with panhypopituitarism due to aneursymal hemorrhage of internal carotid artery and coil embolisation
ea0056p711
Progressive optic glioma and concomitant precocious puberty: case report
ea0056p712
A singular case of hypohidrotic ectodermal dysplasia associated with acromegaly
ea0056p713
Sever hyponatraemia and SIADH secondary Bartezomib: case report
ea0056p714
Hypopituitarism due to cerebral abscess
ea0056p715
Low-symptomatic PRL-secreting pituitary adenoma in patient with morbid obesity
ea0056p716
Cushing's disease, bilateral adrenal hyperplasia and ARMC5 mutation - case report
ea0056p717
Post-traumatic hypopituitarism - a case report
ea0056p718
From adrenal incidentalomas to Cushing's disease
ea0056p719
Somatostatin analogue use to treat visual field loss in acromegaly newly diagnosed in pregnancy
ea0056p720
Late onset adrenocorticotrope deficiency in combined pituitary hormone deficiency caused by a mutation of the PROP1 gene
ea0056p721
Sever protracted hypernatraemia following Hyperosmolar hyperglycaemic state: Case report
ea0056p722
Unusual complication of a pituitary adenoma: Pituitary abscess
ea0056p723
Two year old follow up of Hypophysitis secondary to the checkpoint inhibitor Pembrolizumab - a case report
ea0056p724
Meningoencefalitis as a complication of transsphenoidal surgery of a pituitary adenoma: case report
ea0056p725
A family with Kallmann syndrome due to a novel FGFR1 mutation
ea0056p726
Cushing disease and pregnancy: Report of 2 cases
ea0056p727
Developmental endocrinology
CNNHC: Preliminary results of treatment with recombinant somatropin
ea0056p728
Endocrine Nursing
The value of a holistic needs assessment tool in the care of patients with acromegaly
ea0056p729
Endocrine tumours and neoplasia
The down-regulated Tumour suppressor Wnt Inhibitory Factor 1 (WIF1) regulates non-Canonical Wnt signalling in Pituitary Adenomas (PA)
ea0056p730
Cabergoline treatment results in the case of pituitary microadenoma with co-secretion of growth hormone and prolactin
ea0056p731
Pituitary apoplexy after pregnancy in a patient with microprolactinoma
ea0056p732
Sexually dimorphic gene expression in lactotroph pituitary tumours of different behaviours
ea0056p733
Comparison of clinical and subclinical apoplexy in pituitary adenomas
ea0056p734
Utility of a 3D spheroid cell culture system in neuroendocrine tumors
ea0056p735
Exposure of GH in acromegalic patients associated with sleep apnea, but not other clinical results: Experience of a center from 2006 to 2017
ea0056p736
Female Reproduction
Prolactinomas and Pregnancy: pregnancies medically induced\..
ea0056p737
Sheehan's syndrome: Pregnancy is still possible\..
ea0056p738
Growth hormone IGF axis - basic
Craniofacial fibrous dysplasia and long-term untreated GH excess in McCune-Albright syndrome
ea0056p739
GH replacement therapy (GHRT) in adult patients with GH deficiency (GHD): a long term follow up
ea0056p740
IGF1 level and GH dose adjustmentin adults with GH deficiency (AGHD): experience from a Registry in France
ea0056p741
Hirsutism as presenting clinical sign of acromegaly
ea0056p742
Neuroendocrinology
Desensitization of the human motilin receptor by motilin and motilides
ea0056p743
Clinical and radiological characteristics of patients with primary empty sella
ea0056p744
Serum sodium is inversely related to frailty and bone mineral density (BMD) in human immunodeficiency virus (HIV)-infected patients
ea0056p745
Sox 2 expression in human pituitary adenomas-correlations with pituitary function
ea0056p746
The probability of recurrence of the Cushing's disease within three years after surgical treatment depends on the ACTH and cortisol levels in early post-surgery period
ea0056p747
Metabolic status, body composition and bone mineral density in 85 patients with childhood onset growth hormone deficiency (COGHD) in transition period
ea0056p748
Latest safety outcomes from the PATRO adults study of omnitrope® for the treatment of adult patients with growth hormone deficiency
ea0056p749
The different response of somatotropic system to genistein and daidzein in the rat hypothalamus
ea0056p750
Efficacy and safety of a combinated pasireotide lar, pegvisomant and cabergoline treatment in four cases of aggressive somatotrophinomas
ea0056p751
Pediatric hyperprolactinemia: a review of 25 cases
ea0056p752
Could predict the postoperative rosnance the acromegaly cure?
ea0056p753
Initiation of tolvaptan therapy for mild/moderate chronic SIADH-induced hyponatremia in a day-ward
ea0056p754
Ki67 as a marker of recurrence in craniopharyngioma
ea0056p755
Pituitary abscesses diagnosis and therapeutic approach in a reference unit
ea0056p756
Efficacy and effectiveness of pegvisomant monotherapy in treatment patients with acromegaly - systematic review with meta-analysis
ea0056p757
The occurrence of hyperprolactinemia in a hormonally inactive pituitary adenoma
ea0056p758
Body composition and bone health in patients treated for craniopharyngioma: a retrospective 10 year follow-up study
ea0056p759
Postoperative basal serum cortisol as a predictor of long-term hypothalamic-pituitary-adrenal axis integrity after endonasal transsphenoidal surgery for sellar and suprasellar masses
ea0056p760
Recurrence of hyperprolactinemia after dopamine agonists withdrawal
ea0056p761
A case of impaired vision after cabergoline therapy of macroprolactinoma: case report
ea0056p762
The levels of serum osmolality, sodium, and copeptin as predictors of the development of postoperative diabetes insipidus
ea0056p763
Pregnancy outcomes in women with active acromegaly.
ea0056p764
Rathke's cleft cyst mimiking pituitary apoplexy: a case report
ea0056p765
Quality of life acromegalic patients based on the AcroQoL questionnaire
ea0056p766
Female patients with acromegaly in Russian hypothalamic and pituitary tumors registry (OGGO)
ea0056p767
ACTH-secreting pituitary adenomas surgical outcomes and complications in Endoscopic transsphenoidal pituitary surgery (ETPS)
ea0056p768
Clinical outcomes and complications in Endoscopic transsphenoidal pituitary surgery (ETPS) for Non-functioning pituitary adenomas
ea0056p769
Somatostatin analogues therapy of clinically non-functioning pituitary adenomas- impact on tumour volume and visual field
ea0056p770
Paediatric endocrinology
Therapeutic results of growth hormone substitution in children monitored for a growth hormone deficiency: about a Tunisian population
ea0056p771
GH deficiency in children
ea0056p772
Re-evaluation of GH secretion during the transition age in patients with childhood-onset isolated GH deficiency (IGHD) after GH therapy (GHRx)
ea0056p773
Maternal uniparental disomy of the chromosome 14: a case report of mosaicism
ea0056p774
Final height in cancer survivors undergoing treatment with somatotropin
ea0056p775
Pituitary - Basic
Pregnancy and hypopituitarism: clinical aspects and outcome
ea0056p776
Functional analysis of aryl hydrocarbon receptor (AHR) polymorphisms in pituitary adenomas (PAs) in the presence of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)
ea0056p777
Comparative differential effects of secretagogues upon regulation of pituitary GH in several vertebrates
ea0056p778
Next generation sequencing for characterization of mitochondrial genome in pituitary adenomas
ea0056p779
Pituitary cell activation and recruitment in hipothyroidism
ea0056p780
SOM230 exerts anti-proliferative actions by reducing phospho-ERK1/2 levels in ACTH-secreting pituitary tumour cells
ea0056p781
Abstract unavailable
ea0056p782
Corticotroph pituitary adenomas: the functioning vs the silent: a gene expression study comparing differentially expressed genes in the regulation of POMC
ea0056p783
CGH array analysis of pituitary tumors revealed a highly-disrupted genome
ea0056p784
Treatment with antidiabetic biguanide drugs directly impacts the function of multiple pituitary cell types from two non-human primate models
ea0056p785
Enhanced expression of the transcriptional activators YAP and TAZ in non-secreting pituitary tumours
ea0056p786
Activation of pituitary stem cells through modulation of the LATS/YAP/TAZ cascade
ea0056p787
Pituitary - Clinical
Sheehan's syndrome: clinical and laboratory evaluation of 80 cases
ea0056p788
Metabolic and cardiovascular outcome in patients with Sheehan's syndrome
ea0056p789
Final results of NordiNet® international outcome study: key outcomes
ea0056p790
Relationship between cortisol increment and basal cortisol: implications for the insulin tolerance test in assessing corticotrop insufficiency
ea0056p791
A case of pituitary metastasis in female patient with an invasive breast carcinoma
ea0056p792
Non-classical factors of cardiovascular risk in acromegaly
ea0056p793
A comparison of pituitary function in primary and secondary empty sella: preliminary data
ea0056p794
Thyroid autoimmunity in patients with empty sella syndrome
ea0056p795
Assessment of prevalence and severity of depressive symptoms in patients with acromegaly using the beck depression inventory II (BDI-II) - own observations
ea0056p796
Giant prolactinomas in men: clinical features and therapeutic outcomes
ea0056p797
Static and dynamic balances in acromegaly and impact of exercise on balance
ea0056p798
Severe hypernatremia resulting in a locked-in syndrome
ea0056p799
Thyroid autoimmunity and euthyroid hashimoto thyroiditis frequancy in patients with pituitary adenoma
ea0056p800
Gonadotroph pituitary macroadenoma inducing ovarian hyperstimulation syndrome
ea0056p801
Associated pituitary insufficiencies in children with growth hormone deficiency
ea0056p802
Metastasis - A rare cause of diabetes insipidus and pituitary insufficiency
ea0056p803
Endocrine abnormalities in primary empty sella syndrome
ea0056p804
Long-term outcomes of different treatments for cushing disease: a retrospective study
ea0056p805
Association between prolactin level and tumor size reduction at 3 months after cabergoline treatment in patients with macroprolactinoma
ea0056p806
Predictors of clinical behavior of pituitary adenomas
ea0056p807
The comparison of combination test either with 1 μg acth test and glucagon test for the evaluation of hypothalamo-pituitary-adrenal axis in patients with pituitary disorders
ea0056p808
Clinical parameters to distinguish silent corticotroph adenomas from other non-functioning pituitary adenomas
ea0056p809
Male hypogonadism - when two endocrine causes merge in the same patient
ea0056p810
The diagnostic utility of late night salivary cortisol (LNSF) and cortisone (LNSE) in Cushing's Syndrome and their relationship to metabolic markers
ea0056p811
Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?
ea0056p812
The association between Ki-67 proliferation index, P53 expression, mitotic index, tumor invasion and the risk of recurrence in pituitary adenomas
ea0056p813
Pituitary enlargement due to the autoimmune thyroiditis mimicking a pituitary macroadenoma
ea0056p814
Intracranial germinoma with panhypopituitarism in a 18-year old patient
ea0056p815
Primary pituitary abscess: an unexpected diagnosis
ea0056p816
Diurnal melatonin profile in patients with pituitary adenomas
ea0056p817
Diabetes insipidus due to hypothalamitis and infundibulo-neurohypophysitis
ea0056p818
Age and severity of hyperthyroidism are determinants of thoracic vertebral fractures in patients with TSH-secreting pituitary adenoma
ea0056p819
Cushing disease after remission and prevalence of cardiovascular risk factors
ea0056p820
Clinical relevance of metabolic phenotype in hypopituitarism: what really matters?
ea0056p821
TSH-secreting pituitary adenomas: clinical and morphological characteristics and outcomes of surgical treatment
ea0056p822
Recovery of the adrenal function after pituitary surgery in patients with Cushing Disease: remission or recurrence?
ea0056p823
Hypothalamic involvement in diffuse large B-celllymphoma
ea0056p824
Iceberg alert: undetected health problems in adults with Prader-Willi syndrome - multidisciplinary care could prevent 'unexplained deaths'
ea0056p825
Pituitary apoplexy in pregnancy lead to empty sella
ea0056p826
Benefits of pre-surgical treatment with somatostatin analogs in naive patients with acromegaly
ea0056p827
Temozolomide is effective for rapid control of hypercortisolism in aggressive acth-secreting pituitary tumors
ea0056p828
Cancer in acromegaly: a case-control study
ea0056p829
A rare case of acromegaly with normal IGF-1, severe chronic congestive heart failure, and impaired glucose tolerance
ea0056p830
Two-dimensional speckle tracking echocardiography showed a slight impairment of left ventricular deformability in acromegalic patients at diagnosis and during follow-up
ea0056p831
Trabecular bone score as skeletal fragility predictor in patients with acromegaly
ea0056p832
Registry for central diabetes insipidus in Russia: prevalence and etiologies of the disease
ea0056p833
Two cases of silent corticotroph adenomas
ea0056p834
IgG4-related neuroinfundibulo-hypophysitis treated by rituximab and corticosteroids
ea0056p835
Early postsurgery cortisol after transphenoidal surgery to predict adrenal insufficiency one year posturgery
ea0056p836
Cushing's disease with negative or inconclusive MRI: reassessment of transphenoidal surgery at the age of medical treatment. Post operative remission rate in 184 patients including 86 with negative or inconclusive MRI
ea0056p837
Simultaneous coexistence of Cushing's disease and renal cell carcinoma
ea0056p838
The relationship between sleep apnea syndrome and metabolic parameters in patients with acromegaly
ea0056p839
Early postoperative GH level as biomarker for surgical outcome in patients with acromegaly
ea0056p840
Optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas
ea0056p841
Thicknesses of Chorioretinal layers in Prolactinoma Patients: A Spectral Domain Optical Coherence Tomography Study
ea0056p842
Combined treatment of craniopharyngiomas
ea0056p843
Vitamin D status in acromegaly: a comparative study
ea0056p844
Hypernatraemia and mental disorders
ea0056p845
The use of colonoscopic screening in acromegaly in our everyday practice revisited: how compliant with guidelines have we been?
ea0056p846
The Secret of the Ophtalmopathy
ea0056p847
Tolvaptan usage in hyponatremic patients with syndrome of inappropriate secretion of antidiuretic hormone: a single-center experience
ea0056p848
Real-world data from NordiNet International Outcome Study (IOS) and ANSWER Program provide new insights into the safety of growth hormone in a large cohort of children with Noonan Syndrome
ea0056p849
Hypophysitis: Experience of a single tertiary center
ea0056p850
Pituitary adenomas in childhood and the transition period - clinical and genetic characterization of 49 patients at one tertiary care endocrine institution in Romania
ea0056p851
Psychopathology in Cushing's disease and acromegaly
ea0056p852
Presence of empty sella in a patient with clinical and biochemical diagnosis of acromegaly
ea0056p853
The metabolic disturbances in acromegaly patients in relation to total, acylated and unacylated ghrelin
ea0056p854
Hypopituitarism in primary empty sella
ea0056p855
A first-in-human pharmacokinetic, safety, and tolerability study of pasireotide subcutaneous depot
ea0056p856
HLA celiac haplotypes and Primary Autoimmune Hypophysitis in Caucasian patients
ea0056p857
Consensus on the management of acromegaly in Spain
ea0056p858
PROMPT: a prospective study to assess efficacy and safety of metyrapone in endogenous Cushing's syndrome
ea0056p859
Mind the gap between cortisol levels measured with second generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single center experience
ea0056p860
An open-label, multicentre, single-arm, expanded-access study of subcutaneous (s.c.) pasireotide in patients with Cushing's disease (CD)
ea0056p861
Growth hormone secretion in children treated for medulloblastoma
ea0056p862
Interim results of a non-interventional, observational study evaluating the long-term safety and efficacy of pasireotide sc in Cushing's disease
ea0056p863
An immunohistochemical study on pituitary adenomas
ea0056p864
Inferior petrosal or cavernous sinus sampling in ACTH-dependent Cushing's syndrome: a single center experience
ea0056p865
Relationship between pituitary adenoma size and transsphenoidal pituitary adenoma surgery outcomes: single-centre experience
ea0056p866
Clinical and mri findings among 120 patients with macroproprolactinemia: results from a retrospective study
ea0056p867
Hypothalamic-pituitary axis assessment in a clozapine treated patient with a pituitary adenoma
ea0056p868
Comorbidities and symptoms among patients with acromegaly in italy: a longitudinal retrospective chart review study
ea0056p869
Safety and efficacy of long-acting Pasireotide monotherapy in acromegalic patients treated with a combination of first-generation somatostatin analogs and cabergoline or pegvisomant
ea0056p870
Association between biochemical control and comorbidities and symptoms among patients with acromegaly in Italy: a longitudinal retrospective chart review study
ea0056p871
Trends of insulin-like growth factor 1, growth hormone, and biochemical control of patients with acromegaly in italy: a longitudinal retrospective chart review study
ea0056p872
Pituitary intensity at magnetic resonance imaging is reduced in obese patients: results from the CHIASM study
ea0056p873
The influence of levothyroxine (T4) treatment on metabolic parameters in central hypothyroidism (CH)
ea0056p874
Efficacy of pasireotide lar in first line somatostatin analogue resistant acromegaly patients: experience from a large and single centre Italian cohort
ea0056p875
The change in metabolic parametres of prolactinoma patients after therapy intervention
ea0056p876
Abstract unavailable
ea0056p877
Abstract unavailable
ea0056p878
Radiotherapy for pituitary adenomas - safety and efficacy analysis
ea0056p879
Usefulness of stereotactic radiotherapy in acromegalic patient resistant to conventional treatment
ea0056p880
Subclinical left ventricular dysfunction in patients with naive acromegaly assessed by two-dimensional speckle tracking echocardiography (2D-STE)
ea0056p881
Efficacy and tolerability of cabergoline in a cohort of 160 prolactinomas at weekly doses of up to 9 mg
ea0056p882
Pituitary apoplexy: 15 years of experience
ea0056p883
Clinical and treatment outcomes in patients with craniopharyngiomas - single center experience
ea0056p884
Very high prolactin levels associated to domperidone therapy
ea0056p885
Acromegaly: surgical results and predictors for remission
ea0056p886
Investigation and initial management of hyponatraemia
ea0056p887
Lanreotide autogel may be an effective approach for acromegalic patients who failed octreotide lar
ea0056p888
Poster Presentations: Reproductive Endocrinology
Adrenal cortex (to include Cushing's)
Are there specific biomarkers able to differentiate non classical congenital adrenal hyperplasia (NCAH) due to 21-hydroxylase deficiency from non-NCAH in a population of naive hyperandrogenic women in the reproductive age?
ea0056p889
Bone ' Osteoporosis
Bone mineral density in oligomenorrhoeic women with polycystic ovary syndrome
ea0056p890
Cardiovascular Endocrinology and Lipid Metabolism
Effect of mifepristone on viability of cells of HECa10 line evaluated in real time depends on the duration of exposure and density of cells and allows choosing the proper time point to apoptosis assessment
ea0056p891
An analysis of the cardiovasular risk factor profiles of patients with turner syndrome
ea0056p892
Clinical case reports - Thyroid/Others
A testicular mass in a patient with Klinefelter syndrome
ea0056p893
Postmenopausal virilization with negative imaging
ea0056p894
Hypergonadotropic hypogonadism secondary to vanishing testes syndrome newly diagnosed in a 42-year-old male patient
ea0056p895
Gender identity and assignment in a 46XY DSD-case report
ea0056p896
Type 1 autoimmune polyglandular syndrome - clinical case report
ea0056p897
Triple X and premature ovarian insufficiency - case report
ea0056p898
Developmental endocrinology
A 25 years old male patient with Noonan syndrome and delayed puberty
ea0056p899
Abstract unavailable
ea0056p900
Evaluation of pubertal development in young with type 1 diabetes mellitus: about 200 patients
ea0056p901
Diabetes (to include epidemiology, pathophysiology)
Comparison of diabetes mellitus screening methods for women with polycystic ovary syndrome
ea0056p902
Endocrine Disruptors
Correlational evaluation of inflammatory biomarkers in polycystic ovarian disease: a case control study
ea0056p903
Tumor growth of breast cancer was enhanced by fludioxonil, an antifungal agent, via estrogen receptor-dependent pathways
ea0056p904
Treatment with pesticides, fenhexamid and cyprodinil, resulted in an increase of cell cycle- and metastasis-related genes in an estrogen receptor-dependent pathway in cellular and xenografted mouse models with MCF-7 breast cancer cell
ea0056p905
Relationship of urinary bisphenol A to metabolic and hormonal profile in PCOS women
ea0056p906
Cross hormone therapy in transgender individuals: changes in lipid profile and other cardiovascular risk factor
ea0056p907
Endocrine Nursing
Patient perspectives on sexuality in hypopituitarism
ea0056p908
Testosterone replacement: 'The best practice'
ea0056p909
Endocrine tumours and neoplasia
Resveratrol inhibits DHT-induced metastasis of prostate cancer through interfering with the AR and CXCR4 pathway
ea0056p910
Female Reproduction
Assessment of insulin resistance in polycystic ovary syndrome: HOMA, QUICKI and McAuley indices have only moderate correlation with OGTT-based belfiore index
ea0056p911
Presence of antiphospholipid antibodies is associated with increased failure rates of assisted reproductive techniques: a meta-analysis
ea0056p912
Association between anthropometric parameters and lipid and carbohydrate profiles and CRP as inflammation indicator in women with polycystic ovary syndrome
ea0056p913
The risk of cardiovascular diseases in relation to anthropometric parameters and CRP concentration in a group of women with polycystic ovary syndrome
ea0056p914
Experience of managing primary hyperaldosteronism (HP) during pregnancy
ea0056p915
Beneficial effect of
Ecklonia cava
extract in Letrozole-induced polycystic ovary syndrome rats
ea0056p916
The paracrine endometrium expression in women with autoimmune thyroid imbalance and spontaneous abortion
ea0056p917
Young lean women with evidence of both premature adrenarche and pubarche display a metabolic, hormonal and psychologic profile that is similar to that of their peers with polycystic ovary syndrome
ea0056p918
Endometrium steroid receptors expression in women with autoimmune thyroid pathology and reproductive failures
ea0056p919
Does Crohn's disease have an effect on female fertility?
ea0056p920
Effects of food restriction on estrous cycle and leptin hormone in mongolian gerbils (Meriones unguiculatus)
ea0056p921
Amenorrhea and high intensity training
ea0056p922
Detection of SRY gene in patients with turner syndrome
ea0056p923
Time-dependent regulation of kisspeptin/Kiss1R and TAC3/TACR3 systems expression in human ovarian granulosa cells from polycystic ovary syndrome (PCOS) patients and non-PCOS patients
ea0056p924
Hyperandrogenism in a postmenopausal woman:A clinical challenge
ea0056p925
Polycystic ovary syndrome and insulin-like growth factor (IGF) system.
ea0056p926
Disentangling polycystic ovary syndrome (PCOS) components by liquid-chromatography - tandem mass spectrometry (LC-MS/MS) steroid profiling
ea0056p927
Anxiety and depression in patients with polycystic ovarian syndrome
ea0056p928
A retrospective analysis of the audiometric data of a cohort with turner syndrome
ea0056p929
The relationship between uric acid levels and metabolic parameters in patients with polycystic ovary syndrome
ea0056p930
Pure leydig cell tumor of the ovary in young premenopausal female
ea0056p931
Effect of maternal smoking on steroidogenesis
ea0056p932
Fertility restoration in female patients with hypopituitarism
ea0056p933
The inflammatory markers and central obesity in policystic ovary syndrome
ea0056p934
The clinical utility of serum anti-Mullerian hormone (AMH) in patients aged over 40 with their first IVF treatment
ea0056p935
Child wish and fertility preservation in assigned female at birth transgender persons living in Belgium
ea0056p936
Oral glucose tolerance test vs fasting plasma glucose determination for the assessment of glucose metabolism disturbances in women with Polycystic Ovary Syndrome
ea0056p937
Potential toxicity of cefuroxime therapy on rats' ovary
ea0056p938
Polycystic ovary syndrome (PCOS) associates with dissatisfied body image and weight loss attempts at age 31 and 46 - A prospective, population-based Cohort study
ea0056p939
Subchronic exposure to kalach 360 SL-induced endocrine disruption in female ovaryrats
ea0056p940
Acute and delayed responses of steroidal hormones after a resistance training session: time-of-day effects.
ea0056p941
Recombinant FSH and biosimilars result in different intracellular signaling
ea0056p942
Two cases of Mayer-Rokitansky-Kuster-Hauser syndrome type 2 with bilateral inguinal hernia
ea0056p943
Mayer Rokitansky Kuster Hauser syndrome: a case report
ea0056p944
Current situation of adult patients with Turner syndrome in Tenerife (Spain)Current situation of adult patients with Turner syndrome in Tenerife (Spain)
ea0056p945
Primary amenorrhea due to gonadal gysgenesis in a girl with karyotype 46,XX
ea0056p946
Hormonal and metabolic differences between hyperandrogenic women with PCOS
ea0056p947
Turner Syndrome and Abnormal liver function
ea0056p948
Association of hormonal and metabolic status with carotid intima-media thickness in women with polycystic ovary syndrome
ea0056p949
Oxidative stress markers in women with polycystic ovary syndrome without insulin resistance
ea0056p950
Thyroid axis in women with polycystic ovary syndrome
ea0056p951
Determinants of fatty liver disease in adult women with Turner syndrome
ea0056p952
Is it all about deiodinase after all? Effects of correction normal high tsh in women with infertility on pregnacy outcome
ea0056p953
A case of 17 alpha-hydroxylase deficiency in a 46,XX patient: but where are Mullerian ducts?
ea0056p954
Breast cancer in transgender persons receiving gender affirming hormone treatment: results of a nationwide cohort study
ea0056p955
The role of lipids in prediction of gestational diabetes mellitus
ea0056p956
Biological exploration of hirsutism: Tunisian experience
ea0056p957
A new balanced autosomal translocation as a cause of premature ovarian insufficiency
ea0056p958
Male Reproduction
Infertility caused by Chapelle syndrome
ea0056p959
Endogenous testosterone supports spermatogenesis even in the absence of gonadotrophins: evidence from a case report
ea0056p960
Differential effects of genetically inherited - and high fat diet induced - obesity on spermatogenesis in adult male rats
ea0056p961
Hematological indices in congenital hypogonadism and the effect of testosterone replacement therapy: A retrospective study
ea0056p962
Hypogonadism and mortality in type 2 diabetic men
ea0056p963
Impact of testosterone administration to female-to-male transsexuals on cardiovascular risk factors
ea0056p964
Triglyceride-Glucose index levels in patients with congenital hypogonadism
ea0056p965
Effects of cross-sex hormone treatment on body composition in transgender persons
ea0056p966
Erectile Dysfunction - The hidden sickness we don't seek
ea0056p967
Abstract unavailable
ea0056p968
Leptin targets in the male reproductive tract of mice
ea0056p969
A case of Wolfram syndrome with primary gonadal insufficiency
ea0056p970
Child wish and fertility preservation in assigned male at birth transgender persons living in Belgium
ea0056p971
The relationship between PTEN mutations and resistance to androgen-deprivation therapy in prostate cancer
ea0056p972
Male hypogonadism due to 46, XX Testicular disorder of sex development
ea0056p973
DicentricisochromosomeYp in adolescent with azoospermia
ea0056p974
Prolactin concentration in male-to-female transsexual subjects following cross-sex hormone therapy
ea0056p975
Neuroendocrinology
Abstract unavailable
ea0056p976
Paediatric endocrinology
Association of placental thyroid hormone concentrations with congenital cryptorchidism
ea0056p977
Abnormal uterine bleeding in adolescents: experience of a single center
ea0056p978
Breast hypertrophy (macromastia) in puberty: case report
ea0056p979
Pituitary - Basic
In vitro characterization and comparison of commercial GnRH antagonists
ea0056p980
Steroid metabolism + action
Facial feminization/masculinization: the effect of hormone treatment in transpersons
ea0056p981
Polycythemia in transmen - Prevalence, determinants and outcome in a large cohort
ea0056p982
17-Beta hydroxysteroid dehydrogenase 3 deficiency: Three case reports
ea0056p983
Thyroid (non-cancer)
Relationship between hypothyroidism and androgen deficiency in men in different periods of mature age
ea0056p984
Poster Presentations: Thyroid
Clinical case reports - Thyroid/Others
A silent thyroiditis in the remission period of Graves' disease
ea0056p985
Amyloid goiter secondary to rheumatoid arthritis
ea0056p986
An uncommon but serious hematological manifestation of Grave's disease: Grave's disease induced bicytopenia
ea0056p987
A rare cause of subclinical hypothyroidism: macro-TSH
ea0056p988
Manifestation of thyrotoxic crisis after delivery: clinical case report
ea0056p989
Sunitinib induced myxedema in a patient with metastatic gastrointestinal stromal tumor (GIST)
ea0056p990
Tuberculosis abscess resembling thyroiditis
ea0056p991
Significant cardiac disease complicating Graves' disease in the young
ea0056p992
Thyroiditis in patients with rheumatoid arthritis, related to rituximab
ea0056p993
Pericarditis: uncommon onset of anti-neutrophil cytoplasmic antibody-associated vasculitis induced by methimazol
ea0056p994
Coexistence of hashimoto thyroiditis and De Quervain's thyroiditis
ea0056p995
Tea and juice as a causes of levothyroxine malabsorption and intermittent hypothyreoidism: a case report
ea0056p996
Thyroid-type malignancies in struma ovarii and thyroid gland of two different origins: case report
ea0056p997
Type 1 diabetes mellitus and sorafenib: coincidence or consequence?
ea0056p998
Thyroid arterial embolization for the treatment of large multinodular goiter and hyperthyroidism
ea0056p999
Thyroid hormone resistance and pituitary macroadenoma: is there a connection? - case report
ea0056p1000
Thyrotoxic hepatitis
ea0056p1001
Digestive system diseases associated with Turner's syndrome in 3 pediatric cases
ea0056p1002
Subacute thyroiditis in a patient with Epstein-Barr virus (EBV) meningitis
ea0056p1003
Right heart failure in patient with resistant thyrotoxicosis due to Graves' disease
ea0056p1004
Pharmacologic interference as a contributory factor for spuriously elevated TSH levels
ea0056p1005
Developmental endocrinology
Subacute thyroiditis with coexisting papillary carcinoma - A case report
ea0056p1006
Endocrine Disruptors
Association of Pro-inflammatory cytokines and Benign Thyroid nodules: A prospective case-control study
ea0056p1007
A validated LC-Q-TOF-MS method for quantitative analysis of thyroxine and metabolites in placenta
ea0056p1008
Endocrine tumours and neoplasia
Bethesda System for Reporting Thyroid Cytopathology (BSRTC): Category III and IV Frequency and Risk of Malignancyin the Era of Molecular Testing and after the Reclassification of Non Invasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features (NIFTPs)
ea0056p1009
Thresholds of basal and calcium stimulated calcitonin for diagnosis of medullary thyroid carcinoma
ea0056p1010
Nuclear receptors and signal transduction
Are benign adenoma and papillary thyroid carcinoma related? A linkage study from BRAF and NIS gene mutation point of view
ea0056p1011
Paediatric endocrinology
Characteristics of thyroid dysfunction in children with turner syndrome
ea0056p1012
Thyroid (non-cancer)
Assessment of radioiodine treatment for hyperthyroidism
ea0056p1013
Dyslipidemia in subclinical hypothyroidism: a case-control study
ea0056p1014
An eleven-year-old girl presenting with Graves' ophtalmopathy
ea0056p1015
Choroidal thickness changes in Graves' ophthalmopathy
ea0056p1016
Post-operative hypocalcaemia following open thyroidectomy for benign multinodular goiters using FOCUS harmonic scalpel versus conventional suture ligation technique for hemostasis - a prospective, single-blind, randomized controlled trial
ea0056p1017
Thyroid disorders and gestational diabetes mellitus: more common than we thought
ea0056p1018
Characteristics and outcome of patients with hyperthyroidism attending a hospital endocrine clinic- a retrospective study
ea0056p1019
How evolve antithyroperoxydase antibody in Hashimoto thyroiditis in time: Study on 450 patients: January 2018
ea0056p1020
Hyperemesis gravidarum mimicking thyroid storm- A diagnostic dilemma in early pregnancy
ea0056p1021
Correlation between cytologic results and thyroid autoantibodies, calcitonin, and thyroid function tests in patients with thyroid nodules
ea0056p1022
Percutaneous ethanol injection for benign cystic and mixed thyroid nodules
ea0056p1023
Post partum and non-post partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs
ea0056p1024
Rare association of primary hyperparathyroidism and toxic multinodular goiter
ea0056p1025
The thyrotoxicosis in patients with amiodarone induced thyrotoxicosis may not respond totherapeutic plasmapheresis like patients with Graves' disease
ea0056p1026
Effect of metformin therapy on thyroid stimulating hormone and BMI in hypothyroid egyptian patients
ea0056p1027
IgM thyroglobulin autoantibodies are detectable in serum of patients with subacute thyroiditis
ea0056p1028
Single session treatment of benign thyroid nodules with radiofrecuency ablation: results at 6 months in 17 patients
ea0056p1029
Fibroblast growth factor 23 is elevated in patients with euthyroid Graves' disease
ea0056p1030
Evaluation of the iodine sufficiency of pregnant women in Belarus
ea0056p1031
Thyroid disease in PHPT: a single centre study
ea0056p1032
Clinical importance of incidentally discovered thyroid nodule by carotid artery ultrasonography
ea0056p1033
Thyroid function in relation to pregnancy outcome
ea0056p1034
The assessment of vitamin D3 deficiency in patients with Hashimoto's disease and the relationship between the disease duration and 25OHD3 levels
ea0056p1035
Hypothyroidism treated with weekly intramuscular thyroxine injections
ea0056p1036
Evaluation of thyroid nodule, volume and arterial stiffness in euthyroid individuals
ea0056p1037
Iron deficiency, a risk factor for thyroid dysfunction and autoimmunity in the second trimester of pregnancy in China
ea0056p1038
A rare case of amyloid goiter with concomitant papillary thyroid microcarcinoma in a patient with HIV
ea0056p1039
A thyroid hormone-independent molecular fingerprint of 3,5-diiodothyronine suggests a strong relation with coffee metabolism in humans
ea0056p1040
The benefits of the thyroid disease screening program in pregnant women in Slovakia
ea0056p1041
Level of awareness in hypothyroid patients
ea0056p1042
Predictive value of HLA variants for Graves' disease recurrence - pilot study in Czech patients
ea0056p1043
Usefulness of ultrasound evaluation of thyroid nodules in predicting malignancy
ea0056p1044
Ultrasound in stages of surgical treatment of patients with thyroid diseases
ea0056p1045
Active surveillance of indeterminate thyroid nodules beyond cytological diagnosis, ultrasound evaluation and molecular analysis
ea0056p1046
A case of subacute thyroiditis associated with adalimumab
ea0056p1047
Correlation of recommended diagnostic tools with pathological findings in the thyrotoxic patient
ea0056p1048
Dependency between vitamin D3 and serum titers of the thyroid autoantibodies in smoking cigarettes patients with Graves' disease - one year follow-up - preliminary study
ea0056p1049
Visual evoked potentials in the diagnosis of orbitopathy during the course of Graves' disease
ea0056p1050
Thyroid ultrasound alterations occurrence in patients with previous negative examination: A 6-years observational follow-up trial
ea0056p1051
Evaluation of 32 patients with subacute thyroiditis
ea0056p1052
Cryoablation of goiter irrespective of thyroid profile
ea0056p1053
Prevalence and clinico-epidemiology of hypothyroidism in Indian patients with type-2 diabetes mellitus and hypertension
ea0056p1054
Pos-thyroidectomy hypoparathyroidism: The role and timing of calcium determination
ea0056p1055
Adaptation and cross-cultural validation of the Spanish version of the Thyroid-Related Quality-of-Life Patient-Reported Outcome (ThyPRO) questionnaire
ea0056p1056
Antithyroid drugs can be associated with increased frequency of antibodies against type 2 5'-deiodinase enzyme influencing their therapeutical effectiveness in hyperthyroid Graves' ophthalmopathy
ea0056p1057
The thyroid gland in acromegaly
ea0056p1058
Metabolic profile in patients with subclinical hypothyroidism
ea0056p1059
The efficacy of intrathyroid injected steroids for painful lymphocytic thyroiditis
ea0056p1060
The peripheral blood and thyroid compartment in patients with Graves' disease: helper and regulatory T-cells and decreased B-lymphocytes
ea0056p1061
Influence on remission rates of hyperthyroid periods during anti-thyroid drug therapy of Graves' disease: retrospective study of N=301 patients
ea0056p1062
The accuracy of diagnostic tests in amiodarone-induced thyrotoxicosis; a case-series
ea0056p1063
Arterial stiffness in hyperthyroid patients is deteriorated due to thyroid hormones
ea0056p1064
Gestational and postpartum complications in women with chronic autoimmune thyroiditis receiving iodine and selenium therapy
ea0056p1065
The effects of exenatide treatment on thyroid
ea0056p1066
Evaluation of anti-thyroglobulin antibodies in pregnant women in Area IV of Asturias
ea0056p1067
First extracervical (remote-access) thyroid lobectomy for large specimen without a visible scar via a transoral vestibular and retroauricular approach (TOVARA)
ea0056p1068
Study of possible relation between thyroid volume, nodule formation and glucose metabolism disordersin egyptian population
ea0056p1069
Final diagnosis of thyroid nodules classified as Bethesda-4 after Fine-needle aspiration
ea0056p1070
Thyroid autoantibodies and quality of life in patients with benign thyroid diseases
ea0056p1071
Iodine deficiency in pregnancy - is the situation in poland improving?
ea0056p1072
Serum thyroglobulin as a biomarker of iodine status in pregnant women
ea0056p1073
Metabolic signature of hypothyroidism indicating higher cardiovascular risk
ea0056p1074
Abstract unavailable
ea0056p1075
Effectiveness of radioiodine treatment for toxic adenoma
ea0056p1076
Effective complex treatment of endocrinous ophthalmopathy (EO) with ophthalmic hyperthyroidism resistent to steroid therapy
ea0056p1077
Diminished levels and defective suppression function of Tr1 cells is observed in patients with autoimmune thyroiditis
ea0056p1078
Thyroid amyloidosis mimicking medullary thyroid carcinoma
ea0056p1079
EMPATHY: a new tool for identifying the most suitable thyroxin formulation in hypothyroid patients
ea0056p1080
Coincidental prolactinoma and parathyroid adenoma in a patient with negative MEN1 and MEN4
ea0056p1081
How should thyroid-related quality of life be assessed? Standard recall measures compared with here-and-now measures
ea0056p1082
Radiofrequency ablation of the autonomously functioning benign thyroid nodules: 5-years follow-up
ea0056p1083
Clinical and genetic study of autoimmun thyroid disease in a Tunisian multigenerational family
ea0056p1084
High endocan level is associated with Graves' disease
ea0056p1085
Segregation of S292F TPO gene mutation in three large Tunisian families with thyroid dyshormonogenesis: evidenceof a founder effect
ea0056p1086
When thyroid pathology becomes an emergency: about four cases
ea0056p1087
Dysthyroidism and chromosomal aberrations
ea0056p1088
Riedel's Thyroiditis with Hypothyroidism and Hypoparathyroidism
ea0056p1089
Our experience in the first year of radiofrequency ablation of benign thyroid nodules
ea0056p1090
Utility of 99 Tc-MIBI scintigraphy for the assessment of thyroid nodules with bethesda III cytologies
ea0056p1091
Shopping trip and a thyroid storm
ea0056p1092
Should tocilizumab be a second-line treatment of active, moderate-to-severe Graves' Orbitopathy?
ea0056p1093
Features and determinants of hypothyroidism in patients with major beta thalassemia from Algeria.
ea0056p1094
Serum chemerin and other dyslipidemia markers in patients with autoimmune thyroiditis
ea0056p1095
Current iodine status in a Romanian school-aged children
ea0056p1096
Primary thyroidal paraganglioma in a 60 years old female with thyroid goiter
ea0056p1097
Management particularities of substernal goiter
ea0056p1098
A case of respiratory arrest associated with sepsis induced myxoedema coma
ea0056p1099
Prevalence of thyroid dysfunction in Catalonia from two different registers: pharmaceutical delivery records and diagnostic records (EUthyroid project)
ea0056p1100
Dysthyroid optic neuropathy in Grave's disease: two case reports
ea0056p1101
Conversion from thyroxine-treated autoimmune hypothyroidism to Graves' disease
ea0056p1102
Cholestyramine: a useful therapeutic adjunct in severe thyrotoxicosis
ea0056p1103
Elevated level of serum calcitonin of unknown origin
ea0056p1104
Prevalence of thyroid nodules in thyrotoxicosis detected in pregnancy
ea0056p1105
Analysis of association of vitamin D receptor gene Cdx2 (rs11568820) polymorphism with autoimmune thyroid diseases
ea0056p1106
A case of severe hypothyroidism, correcting to euthyroidism through Graves' disease associated with refractory thyroid eye disease
ea0056p1107
Changes of visfatin/NAMPT serum concentration and its leukocyte expression in hyperthyroidism
ea0056p1108
Congenital hypothyroidism: genes involved in organogenesis disorders
ea0056p1109
Abstract unavailable
ea0056p1110
Intrathyroidal cyst with squamous metaplasia
ea0056p1111
Levothyroxine absorption test: a safe help for difficult cases
ea0056p1112
Pasireotide and Graves' orbitopathy: outcome in terms of efficacy compared to parenteral metilprednisolone; a pilot study
ea0056p1113
Prediabetes and cardiovascular risk factors in patients with autoimmune thyroiditis
ea0056p1114
The significance of rare genetic variants in the thyroid autoimmunity - brief review and our own results on SLC26A4 variants in Hashimoto's thyroiditis
ea0056p1115
High dose metformin in obese PCOS patients with subclinical hypothyroidism
ea0056p1116
Selenium supplementation and progression of Graves orbitopathy
ea0056p1117
Thyroid cancer
Mixed medullary-papillary carcinoma of the thyroid: a case report
ea0056p1118
Epidemiology of thyroid nodules in the United Arab Emirates: five-years tertiary center analysis
ea0056p1119
Thyroid ultrasonographic characteristics and Bethesda results after FNAB
ea0056p1120
The diagnostic value of elastography score and strain indexfor the evaluation of thyroid micronodules
ea0056p1121
Radiofrequency ablation for micropapillary thyroid carcinoma: evaluation of clinical efficacy
ea0056p1122
Prevalence and clinical significance of BRAFV600E mutation in patients with papillary thyroid cancer
ea0056p1123
Association of pro-inflammatory biomarkers in papillary thyroid cancer: a prospective study
ea0056p1124
An unusual association of three endocrine diseases: pheochromocytoma, hyperparathyroidism and papillary thyroid carcinoma
ea0056p1125
Coexistence of well differentiated, poorlydifferentiated and anaplastic thyroid carcinoma in a male patient with neurofibromas: A case report
ea0056p1126
Incidence of recurrent nerve paresis and hypocalcemia after total thyroidectomy - A retrospective Analysis
ea0056p1127
Highly sensitive Thyroglobulin assay in monitoring patients treated for differentiated thyoid cancer in 26 consecutive patients
ea0056p1128
Hounsfield unit value has null effect on thyroid nodules at 18F-FDG PET/CT scans
ea0056p1129
Follicular thyroid carcinoma with late metastasis to kidney in a patient with elevated thyroglobulin levels of unknown source
ea0056p1130
The role of platelet activation and inflammation in patients with differentiated thyroid cancer
ea0056p1131
Incidental thyroid microcarcinoma in benign thyroid diseases: can it encourage total thyroidectomy as the first choice of surgical treatment? (A retrospective study)
ea0056p1132
Incidental thyroid microcarcinoma diagnosed after total thyroidectomy for non-toxic solitary thyroid nodule: A 13-year single surgical-center experience (A retrospective study)
ea0056p1133
The relationship between clinical, morphological and prognostic characteristics of papillary thyroid carcinoma with BRAFV600E mutation assessed immunohistochemically
ea0056p1134
Improved prognostic value of the eighth edition of the AJCC/TNM staging system for differentiated thyroid cancer
ea0056p1135
Quantitative asessments of normal cervical lymph nodes using shear-wave ultrasound elastography
ea0056p1136
ABO blood groups, Rh factor and thyroid cancer risk: To 'B' or not to 'B'
ea0056p1137
A case of anaplastic thyroid carcinoma complicated with thyrotoxicosis
ea0056p1138
Tyrosine kinase inhibitor (TKI) treatment outcome of stage IV-C thyroid differentiated cancer (analyzed by lesion evaluation)
ea0056p1139
Expression of VEGFR2 and clinical response of anaplastic thyroid cancer to lenvatinib
ea0056p1140
Medullary thyroid carcinoma: a case report on the efficacy and safety of combined treatment with Vandetanib and Lanreotide Autogel
ea0056p1141
Increased incidence of thyroid cancer in a spanish tertiary hospital, valladolid, spain: evolution and clinical characteristics, 2002-2016
ea0056p1142
The significance of postoperative calcitonin (CT) levels in the evaluation of disease course in medullary thyroid cancer (MTC) patients
ea0056p1143
Changing treatment trends with radioiodine in thyroid carcinoma at the beginning of 21st century in Castilla-La Mancha (Spain)
ea0056p1144
Chronic lymphocytic thyroiditis is associated with decreased staging of differentiated thyroid cancer
ea0056p1145
Clinical characteristics and prognostic factors in patients with follicular thyroid carcinoma
ea0056p1146
Association between Hashimoto's thyroiditis and thyroid lymphoma
ea0056p1147
Prediabetes and type 2 diabetes mellitus and risk of thyroid cancer
ea0056p1148
The mitochondrial DNA control region might have useful diagnostic and prognostic biomarkers for thyroid tumors
ea0056p1149
Papillary carcinoma detected incidentally in a patient with Graves' disease
ea0056p1150
Determination of the BRAF V600E mutation prevalance at papillary thyroid carcinomas (PTCs) in Turkish population
ea0056p1151
Association between Ospital ng Makati-based thyroid ultrasonography descriptive findings and fine-needle aspiration biopsy with histopathology in the diagnosis of thyroid malignancies
ea0056p1152
Thyroid gland metastasis from a laryngeal mucinous adenocarcinoma: a case report
ea0056p1153
Circulating thyroid autoantibodies are more sensitive than fine needle aspiration in detecting metastatic thyroid cancer
ea0056p1154
Are there any differences between hot and cold nodules according to cytology and histopathology results?
ea0056p1155
Diagnostic accuracy of CNB in tyroid nodules smaller than 1 centimeter
ea0056p1156
Serum thyroglobulin (sTg) before surgery in euthyroid patients with differentiated thyroid cancer (DTC)
ea0056p1157
Coexistence of papillary thyroid carcinoma and autoimmune thyroid disease
ea0056p1158
Analysis of the prognostic factors during I-131 therapy for differentiated thyroid cancer patients using BIOMAT ENDO data base
ea0056p1159
Treatment strategies in medullary thyroid carcinoma - outcome following initial surgery with a curative, debulking or prophylactic intent
ea0056p1160
Thyroid cancer prevalence and pathological features in thyroidectomy patients - five years experience
ea0056p1161
A case of familial follicular thyroid carcinoma
ea0056p1162
Co-incidence of medullary and papillary thyroid carcinoma
ea0056p1163
The prevalence of concomitent non-medullary thyroid carcinoma and primary hyperparathyroidism
ea0056p1164
Visualization of Hepatic Metastases of Medullary Thyroid Carcinoma on Tc-99 Bone Scintigraphy
ea0056p1165
Descriptive analysis of papillary thyroid microcarcinomas in a single-center
ea0056p1166
TSH level and risk of malignancy in patients with thyroid nodules with Bethesda IV Cytopathology System
ea0056p1167
A review of prevalence, reporting, and criteria for further investigation of incidental thyroid nodules reported on computed tomography scanning in an Irish general hospital
ea0056p1168
A review of histology reports of 675 thyroid cancer cases in a single centre over ten years
ea0056p1169
Evolution of tumor markers after external beam radiotherapy in the non-undifferentiated thyroid cancer
ea0056p1170
Natural course of thyroid cancer nodules compared with benign thyroid nodules
ea0056p1171
Risk of thyroid malignancy in large thyroid nodules greater than 4 cm
ea0056p1172
Relationship between microRNA expression levels and tumor size in patients with papillary thyroid carcinoma
ea0056p1173
Correlation of preablative thyroglobulin to the new response to therapy system in differentiated thyroid cancer
ea0056p1174
May hemocytometer parameters be a biomarker in medullary thyroid carcinomas?
ea0056p1175
131I-MIBG as a treatment in medullary thyroid carcinoma with distant metastases.
ea0056p1176
Role of the fine-needle aspiration biopsy of cervical lymph nodes with thyreoglobulin washing tests in management patients with differentiate thyroid cancer.
ea0056p1177
Malignancy risk stratification of thyroid nodules with cytological diagnosis of folicular neoplasm (Bethesda IV), according to the ultrasound sonographic patterns proposed by the American Thyroid Association (ATA)
ea0056p1178
A rare case of mixed medullary and papillary thyroid carcinoma related with heterozygous VAL804MET mutationa rare case of mixed medullary and papillary thyroid carcinoma related with heterozygous VAL804MET mutation
ea0056p1179
Validity of sonographic pattern risk in thyroid nodules by the American Thyroid Association (ATA) and citological malignancy diagnosis
ea0056p1180
The role of thyroid imaging, reporting and data system scores - ACR TI-RADS in thyroid nodular disease - our expirience
ea0056p1181
May cinacalcet improve psychiatric symptoms by decreasing calcium levels in lithium-associated hyperparathyroidism?
ea0056p1182
Pediatric thyroid cancer is associated with more aggressive phenotype and more frequent RET/PTC rearrangements compared with the adult patients
ea0056p1183
Serum osteopontin levels in newly diagnosed thyroid cancers
ea0056p1184
First report of c.1683A>G FLT3 mutation found in the follicular thyroid cancer
ea0056p1185
Thyroglossal duct cyst papillary carcinoma: case report and review of literature
ea0056p1186
Thyroid imaging reporting and data system: how useful is it in distinguishing follicular adenomas from follicular carcinomas?
ea0056p1187
Descriptive study about clinical and surgical characteristics of patients with differentiated thyroid cancer in our health area
ea0056p1188
Thyroid ultrasonography and fine needle aspiration: a center experience
ea0056p1189
Brain metastases from papillary thyroid carcinoma, 31 years later
ea0056p1190
Ectopic thyroid tissue challenge: clinical case report
ea0056p1191
Tyrosine kinase inhibitors in iodine-refractory thyroid cancer. Clinical experience
ea0056p1192
Correlation between TSH level and benignity and malignancy of thyroid nodules (about 250 cases)
ea0056p1193
Efficacy and toxicity of lenvatinib treatment for radioiodine refractory thyroid cancer in daily clinical practice: a single centre experience
ea0056p1194
Comparative study about clinical characteristics at the moment of surgery and follow-up depending of histological type in patients with differentiated thyroid cancer in our health area
ea0056p1195
Insular carcinoma of the thyroid diagnostic and prognostic evaluation
ea0056p1196
Amiodarone - thyrotoxicosis and thyroid cancer
ea0056p1197
Thyroid carcinoma in adolescents and young adults (about 120 cases)
ea0056p1198
Anaplastic thyroid cancer: a diagnostic and therapeutic challenge
ea0056p1199
RET exon 11 genotype in medullary thyroid cancer
ea0056p1200
Serum TSH levels as a predictor of thyroid cancer
ea0056p1201
Impact of pregnancy on follow-up of thyroid papillary carcinoma:About 30 cases
ea0056p1202
Comparative study about differences in staging and prognosis in patients affected or not of BRAF V600E mutation
ea0056p1203
Synchronous thyroid disease in patients with primary hyperparathyroidism
ea0056p1204
Association of thyroid papillary carcinomaand an ectopic parathyroid adenoma
ea0056p1205
ePoster Presentations
Adrenal and Neuroendocrine Tumours
Is pheochromocytoma a diagnostics chameleon indeed? Series of cases
ea0056ep1
Gastric NET due to atrophic gastritic combined with multiglandular syndrom type 3
ea0056ep2
Neuroendocrine carcinoma of the ampulla of Vater diagnosed preoperatively by endoscopic biopsy
ea0056ep3
Diazoxide induced acute renal failure in patient with insulinoma
ea0056ep4
Isolated pheochromocytoma associated with mutation in the SDHAF2 (SDH5) gene: rare and challenging clinical case
ea0056ep5
Co-existence of malign insulinoma and diabetes mellitus
ea0056ep6
An atypical pheochromocytoma presenting with clinical sign and symptoms of non-mechanical bowel obstruction
ea0056ep7
Malignant and multifocal metastatic pheochromocytoma: a case report
ea0056ep8
Case report: management of a patient with malignant insulinoma
ea0056ep9
A case of oncocytic adrenocortical neoplasm of borderline malignant potencial
ea0056ep10
About a case of an association of two neuroendocrine tumors
ea0056ep11
The changing of clinical scenario in three consecutive generations of a Brazilian Family with Von Hippel-Lindau disease
ea0056ep12
Hypothyroidism occurrence during treatment of neuro endocrine tumor
ea0056ep13
Patient harboring RET D631Y mutation with long history of pheochromocytoma without evident medullary thyroid carcinoma
ea0056ep14
IGF-2-oma: a diagnosis to be considered in a patient with a leiomyosarcoma and recurrent hypoglycemia
ea0056ep15
Patient experiences with continouous subcutaneous hydrocortisone infusion (CSHI)
ea0056ep16
Adrenal ganglioneurosis
ea0056ep17
Independent ACTH Cushing's syndrome due to unilateral adrenocortical hyperplasia: two cases report
ea0056ep18
Adrenal ganglioneuroma: a case report
ea0056ep19
Malignant sympathetic paraganglioma - case report
ea0056ep20
Bilateral pheochromocytoma in Von Hippel-Lindau syndrome: a case report
ea0056ep21
Composite pheochromocytoma with neuroblastoma: a case report
ea0056ep22
Intestinal pseudo-obstruction as a fatal complication of a malignant hereditary paraganglioma: A case report
ea0056ep23
Thyroid nodule and flush syndrome: it's not always a medullary thyroid carcinoma
ea0056ep24
Chemodectoma of carotid glomus coexisting with severe hypercalcemia masking parathyroid gland adenoma - diagnostic difficulties
ea0056ep25
Neuroblastoma in 55-year-old patient - the role of MIBG scintigraphy
ea0056ep26
Optic neuritis and ectopic Cushing Syndrome: a case report
ea0056ep27
The infradiagnosis of primary aldosteronism as a public health problem
ea0056ep28
Calcium and Bone
Patient with post-surgical hypoparathyreoidism and long QT interval
ea0056ep29
Evaluation of causes of high parathyroid hormone levels in elderly
ea0056ep30
Interventional study to compare two regimens of vitamin D suplementation
ea0056ep31
Atypical parathyroid adenoma - a rare case of primary hyperparathyroidism
ea0056ep32
Correlation levels of parathyroid hormone (PTH) and vitamin D (25(OH)D) in different age groups
ea0056ep33
Bone mineral density and polymorphisms of the estrogen receptor gene,vitamin D receptor gene and collagen typei alpha 1 gene
ea0056ep34
Diabetes, Obesity and Metabolism
Do our diabetic patients really manage to recognize hypoglycaemia and to act properly in front of it?
ea0056ep35
Primary mitochondrial disorders and diabetes mellitus - two case reports
ea0056ep36
Features of distribution of fat component in patients with type 2 diabetes mellitus giving insulin
ea0056ep37
Hyperglycemia and thyroid disorders in chronic hepatitis C virus infected patients in Fayoum, Egypt
ea0056ep38
The prevalence of risk factors for type 2 diabetes among workers of the industrial enterprisein Minsk with FINDRISK questionnaire
ea0056ep39
Vitamin D status in a population of type 1 diabetics
ea0056ep40
Diabetic ketosis profile during the month of Ramadan what are the specificities?
ea0056ep41
Evaluation of microcirculation in patients with diabetes mellitus by laser doppler fluorometry
ea0056ep42
Serum levels of vitamin B12 in cobalamin deficient subjects with or without diabetes mellitus
ea0056ep43
Are plasmathyrotropin levels associated with degree of obesity and metabolic syndrome in euthyroid obese patients?
ea0056ep44
The efficacy of glp-1 analogue therapy in patient with hypotalamic obesity
ea0056ep45
Relation between eating behaviors, exercise and weight loss in post bariatric period
ea0056ep46
Weight loss 6 months after sleeve gastrectomy
ea0056ep47
Diabetes during paraneoplastic cushing: about two cases
ea0056ep48
Diabetes profile during cyclic Cushing syndrome: about one case
ea0056ep49
Diabetes mellitus development secondary to chronic pancreatitis in a kidney transplant recipient
ea0056ep50
Familial chylomicronemia with multiple complications
ea0056ep51
Association of hyperlipidemia with cancer colon
ea0056ep52
Vascular surgeons: do they ask enough?
ea0056ep53
Diabetes and other frequent clinical problems in patients admitted in vascular surgery
ea0056ep54
The risk of symptomatic hypoglycemia over 4 years of intensive insulin treatment and combined therapy in type 2 diabetes patients
ea0056ep55
An uncommon case of diabetic mastopathy
ea0056ep56
Dermatologic manifestations ofdiabetes mellitus-diabetic thick syndrome
ea0056ep57
Influence of vitamin D therapy on albuminuria in patients with type 2 Diabetes mellitus
ea0056ep58
Gender differences in patients with coronary heart disease and diabetes. A retrospective study
ea0056ep59
Diabetic foot ulcers (DFU) in eastern India: an observational
ea0056ep60
What is the knowledge of a population of Tunisian diabetic women on the diabetic foot?
ea0056ep61
Predictive factors of hyperuricemia in diabetics Type 2: About 168 cases
ea0056ep62
Sympathetic hyperactivity and sleep disorders: is Type 2 diabetes the link between these two situations?
ea0056ep63
Awareness of gestational diabetes, its risk factors and its consequences among tunisian pregnant women
ea0056ep64
Characteristics of insulin-requiring diabetes among elderly patients in hospitals
ea0056ep65
Alterations in intestinal microbiota and arginase activity in leukocytes of type 1 diabetes patients
ea0056ep66
Reduction of glycemic variability in a patient with type 1 diabetes with hipoglycemia
ea0056ep67
Diabetic ketoacidosis and dapagliflozin: a case report
ea0056ep68
When is it possible to withdraw insulin in patients with type 2 diabetes and multiple cardiovascular risk factors? Can the new drugs be of help?
ea0056ep69
Controversies of endocrine treatment in Prader-Willi syndrome: a case report of two monozygotic twins
ea0056ep70
Evaluation of diabetes and cardiovascular risk factors in a population of diabetic patients in a rural area
ea0056ep71
Type 2 diabetes: an unexpected journey
ea0056ep72
Clinical case of late diagnosed diabetes in ketoacidotic coma III in teenager: lessons to be learned
ea0056ep73
Role of the dentist in managing obese patients and patients with diabetes mellitus - why oral health matters?
ea0056ep74
Mucormycosis in a patient with diabetes and orbital trauma
ea0056ep75
From severe metformin-associated lactic acidosis to colorectal cancer diagnosis, case-report
ea0056ep76
Diabetic ketoacidosis and myocardial 'pseudoinfarction'
ea0056ep77
Childhood granuloma annulareas first sign of diabetes mellitus: case series
ea0056ep78
Parapharyngeal abscesses of dental origin in diabetics
ea0056ep79
Mental health and diabetes - are we doing enough for our patients?
ea0056ep80
Calculation of the risk of non-compliance with antihypertensive treatments in diabetic patients
ea0056ep81
Deep abscess in the diabetic patient
ea0056ep82
Abscess in the diabetic patient
ea0056ep83
A case report of MODY 2 treated as type 2 diabetes mellitus in pregnancy
ea0056ep84
Impact of magnesium deficiency on chronic complications of type 2 diabetes
ea0056ep85
Severe hypertriglyceridemia in type 1 diabetes accompanied by acute pancreatitis and organomegaly
ea0056ep86
Diabetic ketoacidosis and acute pancreatitis associated with antipsychotic drugs: report of a case
ea0056ep87
Diabetic ketoacidosis, hypertriglyceridemia and acute pancreatitis- a case report
ea0056ep88
Implications of dietary omega-3 fatty acid supplementationon oxidative damage and inflammatory response in type 2 diabetic depressive patients
ea0056ep89
Psychosis because of alcohol abstinence in a diabetic subject
ea0056ep90
Environment, Society and Governance
Selfie driven thyroid disease leads (SET): a study on a unique phenomenon from Surgical Endocrinology Department
ea0056ep91
Interdisciplinary endocrinology
FGF21 levels in patients with breast cancer
ea0056ep92
Pharmacological chaperones for rescue of the mutant AVPR2s
ea0056ep93
Tolvaptan; OPC-41 061, Mozavaptan; OPC-31 260, OPC-21 268 as pharmacological chaperones to rescue of mutant AVPR2s
ea0056ep94
A case with autoimmune polyglanduler syndrome type 3A
ea0056ep95
Cardiotoxicity from glycyrrhizic acid inhibition of 11-beta steroid dehydrogenase
ea0056ep96
Stein leventhal syndrome: a report of two cases
ea0056ep97
Diabetes mellitus reveals malignant vaterian ampulloma
ea0056ep98
Where is the hitch in our interdisciplinary approach? Perceptions of health care providers towards the challenges at diabetes management clinics in Oman
ea0056ep99
Pituitary and Neuroendocrinology
Characteristics of clinical and morphological features of functioning and nonfunctioning pituitary adenomasand disorders commonly associated with them
ea0056ep100
Prolactinoma management: factors that might predict remission of the disease after 12 months of treatment
ea0056ep101
A differentiated approach to the treatment of pituitary apoplexy
ea0056ep102
Unusual association: turner syndrome and anterior pituitary insufficiency in 6 cases
ea0056ep103
Evaluation of differential diagnosis and treatment stages of TSH-secreting pituitary microadenoma which responding to cabergoline therapy
ea0056ep104
Case presentation: Double non-functioning pituitary adenomas
ea0056ep105
Rare combination of Acromegaly and Klinefelter syndrome
ea0056ep106
Could it be recurrent immunoglobulin G4-associated inflammatory mass at the hypothalamic region?
ea0056ep107
Rheumatoid arthritis, acromegaly, primary hyperparathyroidism - what's next?
ea0056ep108
Ectopic clival prolactinoma with empty sella in a patient using antipsychotic
ea0056ep109
Clinical profile of patients with hyperprolactinemia: a study based on nepalese population
ea0056ep110
GSP
gene mutation in a sample of Iraqi acromegalic patients and their response to long-acting repeatable octerotide
ea0056ep111
Quality of life of patients with active acromegaly which didn't underwent surgery
ea0056ep112
Serum concentration of insulin-like growth factor I (IGF-I): reference values for adult Romanian population: Preliminary results
ea0056ep113
Hyponatremia as a first symptom of hypopituitarism due to pituitary metastasis of gastric cancer: Case study
ea0056ep114
Macroprolactinemia diagnosed in a patient evaluated for primary infertility
ea0056ep115
Clinical characteristics and management of 4 patients with chordomas of the skull base attending Beaumont Hospital
ea0056ep116
GH/TSH secreting adenoma: a clinical case report: GH/TSH secreting adenoma: a clinical case report
ea0056ep117
Antiphospholipid syndrome and pituitary necrosis
ea0056ep118
A rare emergency case in endocrinology: pituitary apoplexy
ea0056ep119
Macroprolactinoma found in obesity setting: case report
ea0056ep120
Emotional disorders in patients with tumors of diencephalic localization
ea0056ep121
Clinical improvement of hyperglycemia after use of octreotide lar in a patient with acromegaly who presented with nonketotic hyperosmolar state
ea0056ep122
Frequency of associated diseases in risk groups of a syndrome of Cushing in the Khorezm, Namangan and Kashkadarya regions of the Republic of Uzbekistan
ea0056ep123
The characteristic of the index of body weight in risk groups of a syndrome of Cushing in the Khorezm, Namangan and Kashkadarya regions of the Republic of Uzbekistan
ea0056ep124
Dynamics of indicators of the questionnaire of QoL AGHD at assessment of quality of life at patients after 3 months and 6 months after operation of transnasal pituitary adenomectomy by the replacement treatment growth hormone Djintropin
ea0056ep125
Years of Misery: a final resolution 'panhypopituiatirsm'
ea0056ep126
Prolactinoma and granulomatous mastitis
ea0056ep127
Epidermoid cyst of the sella turcica: about a case
ea0056ep128
Adult onset hypopituitarism - a surprising diagnosis in a postmenopausal women
ea0056ep129
Abstract unavailable
ea0056ep130
Gonadotropinoma without clinical function
ea0056ep131
Pitfalls in the management of inadequate TSH in the outpatient endocrine clinic: a case report
ea0056ep132
Galactorrhoea, severe anxiety and an unexpected outcome
ea0056ep133
A case of acromegaly and Cushing's syndrome
ea0056ep134
Clinical and diagnostic features of prolactinomas
ea0056ep135
Reproductive Endocrinology
The clinical management and follow-up of adults with Turner's syndrome in University College Hospital Galway
ea0056ep136
Etiological profile of premature ovarian failure: about 42 cases
ea0056ep137
Evaluation of dynamic thiol-disulphide homeostasis in healthy postmenopausal women
ea0056ep138
Correlation of LH and FSH with serum TSH levels in polycystic ovarian syndrome
ea0056ep139
Ameliorating effect of Cuscuta japonica chois (CJC) extract on hind-limb ischemic mice
ea0056ep140
Differences in the use of contraception between Roma and non-Roma women in Hungary
ea0056ep141
Atypical presentation in a patient with 45,X/46,X,i (X) (q10) Isochromosome Xq in mosaic turner syndrome: a case report
ea0056ep142
Serum 25-Hydroxy vitamin D levels and insulin resistance in polycystic ovary syndrome
ea0056ep143
Endocrine disruption and oxidative stress implications of imipenem therapy in the ovary of 'wistar' rats
ea0056ep144
The combination of cardiovascular risk factors in PCOS and the risk for cardiovascular disease events
ea0056ep145
Endometrioid adenocarcinoma of abdominal wall in histerectomized patient 18 years before
ea0056ep146
From aneuploidy to eyploidy: a spontaneous, uncomplicated pregnancy in a patient with 45X0/47XXX mosaicism
ea0056ep147
Birth weight of children born to women with AITD compared with those born to women without AITD
ea0056ep148
[ldquo]Gym and anabolists[rdquo]
ea0056ep149
Amenorrhea and benign intracranial hypertension as an effect of antipsychotic therapy in a patient with schizophrenia
ea0056ep150
Hirsutism in patients with polycystic ovary syndrome
ea0056ep151
Evolution of premature ovarian failure after 15 years of follow-up
ea0056ep152
Diagnostic difficulties in precocious puberty
ea0056ep153
Mayer-Rokitansky-Kuster-Hauser syndrome type II
ea0056ep154
Thyroid
Thyroid disease in very elderly patients
ea0056ep155
Pituitary hyperplasia secondary to congenital primary hypothyroidism in adult patient
ea0056ep156
Abstract unavailable
ea0056ep157
What should be the cut-off level for antithyroperoxydase antibody? January 2018
ea0056ep158
Total thyroidectomy can be a radical method of treatment of Grave's disease in alcohol addicted patient who has hepatitis B at the same time, because medical treatment can aggrivate liver disease and bring to recurrence of Grave's disease
ea0056ep159
The complications of diseases of thyroid gland at children and teenagers according to data for 5 years
ea0056ep160
A TSH pituitary adenoma due to Hashimoto Thyroiditis and L-tiriiodotironin treatment experience: Case report
ea0056ep161
Expectant management in patients with multinodular goiter: expected development options
ea0056ep162
The effects of vitamin D supplementation on insulin resistance in patients with hypothyroidism
ea0056ep163
Clinical and morphological characteristics of the first time nodular goiter
ea0056ep164
Thyrotoxic vomiting: an unusual presentation
ea0056ep165
Thyrotoxic periodic paralysis: a rare complication of hyperthyroidism for 21-year-old male.
ea0056ep166
Graves disease, pericarditis and thymus hyperplasia: the improbable triad!
ea0056ep167
Familial dysalbuminaemic hyperthyroxinaemia, a thyroid conundrum
ea0056ep168
Two cases of Graves dermopathy: A rare and pathognomonic symptom
ea0056ep169
BsmI, TaqI, ApaI and FokI VDR polymorphism in women wit and without goiter
ea0056ep170
An unusual presentation of Graves' Ophtalmopathy: About 3 cases
ea0056ep171
BRCA1 mutations and polyporphisms in women with and without goiter
ea0056ep172
Simultaneous occurrence of papillary and medullar thyroid carcinoma report of a case
ea0056ep173
Graves' ophthalmopathy presenting with hypothyroidism
ea0056ep174
Cretinism and language delay are rare manifestations of central hypothyroidism: 2 cases report
ea0056ep175
Strumectomy in nodular goiter - does it make sense? Reflections after 22 years of observation of one patient
ea0056ep176
Simultaneous medullary and papillary thyroid cancer in Graves-Basedow disease. Two case reports
ea0056ep177
A rare case of hurthle cell adenoma and parathyroid adenoma
ea0056ep178
Prognostic factors affecting neck lymphnode recurrence and distant metastasis in papillary thyroid cancer: results of a study in 40 patients
ea0056ep179
The association of breast cancer and thyroid cancer: what relationship? (Preliminary results)
ea0056ep180
Association thyroid carcinoma and lung adenocarcinoma
ea0056ep181
The concept of idiopathic myxedema: The relationships between hypothyroidism and ATPO evolutive level
ea0056ep182
The frequency, specification of diseases of thyroid gland at children and teenagers according to data for 5 years and the kinds of surgical treatment[rdquo]
ea0056ep183
Role of thyroid dysfunction in patients with menstrual disorders
ea0056ep184
It is a link between gallstone disease and pathology of thyroid gland
ea0056ep185
Graves' disease in a patient with myasthenia gravis: a case report
ea0056ep186
Case report and literature review. surgical management of hyperthyroidism in pregnancy
ea0056ep187
Comparison of results of cytological and hystological research of thyroid gland nodes
ea0056ep188
Incidence of thyroid cancer among patients with thyroid nodules
ea0056ep189
Insights from large-scale mHealth data: the impact of Levothyroxine dosage on intensities of symptoms experienced by Hashimoto's patients
ea0056ep190
Autoimmune thyroid disease (Hashimoto thyroiditis) disscussions as possible predicting of thyroid papillary microcarcinoma (MPTC)
ea0056ep191